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This study uses Medicare claims from 1997 and 2004 to examine two
important health policy issues using patients with ischemic stroke as an example.
We explore the differences in rehabilitation services utilization and expenditures
for stroke prior to and after outpatient rehabilitation caps were enacted. We then
examine the effect of using a total cost approach versus a marginal cost method
to estimate the first year cost of stroke and stroke rehabilitation. We found the
cap did constrain outpatient rehabilitation utilization and cost of rehabilitation
services if examined only using Medicare Part B provider costs, but not when
facility costs were also included. Use of a marginal costing approach was
superior to average costing. Indeed, the average costing approach may be
expected to inflate the estimated 2004 SC total cost due to stroke for Medicare
patients by $3.6 billion, because this approach ascribes expenditures for
comorbid conditions to stroke.
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1. INTRODUCTION
Stroke is the third most common cause of death in the United States (US)
and South Carolina (SC), after heart disease and cancer (CDC, 2009). Even
more challenging, stroke is the leading cause of long-term disability (Roger, Go
et. al., 2011 a). The American Heart Association (AHA) estimates new or
recurrent stroke incidence in the US annually at approximately 795,000 (Roger,
Go et. al., 2011 a).
In 2010, it is projected that stroke related costs will reach an estimated
73.7 billion dollars in the US alone (CDC, 2009). Hospitalization costs from stroke
in SC were estimated at $499 million in 2008 (SC Office of Chronic Disease
Epidemiology and Evaluation, 2009) with additional indirect costs due to lost
productivity to be estimated at another $190 million (Mackay J., 2010).
The National Heart, Lung and Blood Institute identified eleven US states
(Alabama, Arkansas, Georgia, Indiana, Kentucky, Louisiana, Mississippi, North
Carolina, South Carolina, Tennessee, and Virginia) with stroke death rates that
were more than 10 0/0 higher than the US average (National Heart Lung and
Blood Institute, 2009). Ten of the 11 states cluster in the southeastern US and
are designated the "stroke belt" because of their higher incidence of stroke and
stroke-related deaths (Casper, Wing et. al., 1995; Howard & Howard, 1995;
Howard, Evans et. al., 1995). South Carolina has one of the highest stroke
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mortality rates (130 per 100,000) in the US and is considered to be a member of
the "Stroke Belt" (SC Office of Chronic Disease Epidemiology and Evaluation,
2009). South Carolina and specifically Charleston, lies in the "Low Country" or
low-lying coastal plains of S.C. which has the distinction of being part of the
"stroke buckle" where stroke rates are the highest in the nation (Howard &
Howard, 1995).
Ischemic stroke accounts for 87% of all strokes, with the remaining
strokes falling into one of the hemorrhagic categories (Benesch, Witter et. a/.,
1997; CDC, 2009). Interventions to treat acute ischemic stroke are now available
and are increasingly being used which could effectively reduce mortality rates,
however, long-term morbidity due to stroke-related impairments are expected to
increase. These increases are likely to be further exacerbated by the aging
population of baby boomers in the US
In addition to the impact of population aging and stroke morbidity rate
increases on stroke rehabilitation needs, governmental policy changes may also
play an influential role in the utilization and cost of post-stroke rehabilitation. The
federal Balanced Budget Act of 1997 (BBA 1997) included a series of changes in
Medicare regulations aimed at cost containment. One of the regulations in the
BBA 1997 included a $1,500 annual cap on outpatient therapy services. The cap
included an annual limit of $1,500 in occupational therapy service expenditures
per Medicare participant, and a $1,500 cap on combined physical and speechlanguage therapy per annum, per participant. The effective date of this capitation
program was January 1, 1999. Due to the tendency of the healthcare industry to
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adjust to major legislation before the legislation takes effect, it is likely that, even
in the years after the effective date where there existed a moratorium on the
rules being enforced, outpatient rehabilitation services utilization and rehab costs
went down even though the needs likely increased. The effect of major federal
health care policy changes have been seen outside of effective dates in the past,
such as with the implementation of the diagnostic related group (DRG) based
prospective payment system in the 1980s and 1990s (Schwartz & Mendelson,
1991 ).
Even with Medicare's attempts to contain costs, the total cost of chronic
illness in the US continues to rise. Some speculate that the cost of treatment
after ischemic Stroke will increase due to the decrease in mortality and
subsequent increase in morbidity due to trend of stroke survivors living longer
with stroke-related disabilities. These suppositions are very difficult to confirm or
deny due to the variability in cost of illness research models and methods.
However, because there has been an increase in the comorbidity in the elderly
population, an understanding of marginal cost of stroke, over and above normal
expected medical care, is the most valuable cost benchmark to follow over time.
Furthermore, it is important to know what proportion of post-stroke health
services is rehabilitation-related care, both for planning purposes and to establish
evidence that will drive future federal regulation and policy.

Therefore, this study examined the cost of ischemic stroke in the state of South
Carolina in order to improve our understanding of:
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1)

post-stroke rehabilitation service utilization and cost changes
between 1997 and 2004, and

2)

the 2004 marginal cost of stroke (a measure of the cost of stroke,
over and above normal costs expected in a similar non-stroke
population), and the proportion of marginal costs attributable to
rehabi litation.

Our findings will contribute to improving baseline estimates of stroke and
rehabilitation costs as well as to inform policy decisions related to Medicare
financing.

AIM 1

To examine the cost and utilization of rehabilitation services (physical
therapy (PT), occupational therapy (OT), speech language pathology (SLP»,
before and after the 1997 Balance Budget Act.
Rationale of Importance

It is important to understand the effects of structural changes in
governmental health care cost containment regulations (therapy caps) on the
process of rehabilitation services utilization and outcome of cost.
AIM 2

To determine the cost of stroke-related healthcare and stroke-related
rehabilitation care for South Carolina Medicare patients in 2004 and examine
what proportion of the cost is rehabilitation-related.
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Rationale of Importance
Cost of illness has been historically reported as direct total healthcare cost
and has never been compared as a marginal cost difference with an equally ill,
non-stroke, control group. Therefore the outcome of cost of illness has been
historically misrepresented in a population that tends to have a great amount of
healthcare costs that are related to comorbidities. The over-estimation caused by
estimating cost of illness using total cost of care, results in an under-estimation of
the impact and need for stroke rehabilitation.

2. THEORETICAL BACKGROUND
Stroke is a highly prevalent disease that can result in death or long-term
debilitating impairments. Impairments can include: speech, swallowing, cognitive,
and physical disability. At the same time some individuals experiencing a stroke
do not survive. Studies show that stroke-related mortality appears to be on a
downward slope, due in part to standardized treatment protocols for acute stroke
treatment. This reduction in mortality from stroke is likely to result in an increase
in the number of individuals with impairments requiring practitioners to transfer
some of their research focus from acute treatment to long-term management of
chronic stroke-related functional limitations.
As with other common chronic diseases, such as heart disease and
cancer, mortality rate decreases are accompanied by greater requirements for
chronic care and attention from the patient, caregivers, and the health-care
community as a whole. What differentiates stroke from other chronic diseases is
the magnitude of the impact of the disease on quality of life and productivity due
to functional impairments.
Unfortunately society is required to assume much of the economic burden
of stroke morbidity as many stroke survivors are over 65 years of age; and
therefore, they receive primary healthcare support through Medicare. As more
baby boomers reach the Medicare age range, we hope to experience what has
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been seen in this group until now, a generally healthier population. The baby
boom generation is retiring later, or not at all, and being more productive than
has been seen in earlier generations. This being said, the impact of post-stroke
impairments in the baby boom generation may become an even greater burden
on society unless advances in post-stroke rehabilitation practices and outcomes
are realized. For these reasons it is imperative that we advance the research of
rehabilitation which has fallen behind the multiple decades of research and
knowledge gains in the medical management of stroke during acute care.
Rehabilitation professionals are striving to advance the understanding of
which practices are best, in whom, when, and how much, without the benefit of
knowing what is being done in the current practice of post-acute stroke care.
There is little evidence to show how much rehabilitation stroke survivors are
currently receiving even though clinical practice guidelines suggest a
comprehensive team of rehabilitation specialists (physical therapists (PT),
occupational therapists (OT), speech language pathologists (SLP), ect.) evaluate
every individual who has survived a stroke. There is even less evidence to show
that increases in rehabilitation contact hours results in greater productivity and
quality of life, and less cost to society. In addition, the research community does
not have a clear and consistent idea of the marginal cost of stroke and what
portion of the cost is rehabilitation-related.
This evidence is needed to help benchmark changes that we will see in
the future as well as to help guide research to answer the all-important, "who,
when and how much" clinical questions as well as the "at what cost to patients
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and society" policy questions. Knowing these benchmarks will also provide
evidence to support policies that will guide how much rehabilitation care is
supported by the healthcare payment system. Good, long-term, evidence is
currently needed to support the expected increase in spending in the short-term
to recover much greater savings in the longer-term while also achieving optimal
outcomes.
In the following sections, I will review the epidemiology of stroke and
current mechanisms to receive and pay for rehabilitation services in the United
States. This research was completed using South Carolina (SC) Medicare data,
a state that bears a significant burden of stroke. I will also review current
evidence for rehabilitation services post-stroke and I will also consider issues
related to what is known about cost and access to rehabilitation after stroke, as
well as the possible impact of health-care policy on clinical practice.

2.1. Stroke Population Statistics
It is estimated that 7,000,000 Americans have had a stroke, indicating a
prevalence in the population of 3% (extrapolated to 2008 from NHANES 20052008 data) (Roger, Go et. al., 2011a). The AHA estimates stroke prevalence in
the US annually at approximately 795,000, with new strokes accounting in
610,000 of these (Roger, Go et. al., 2011a). In 2007, approximately 1 in 18
deaths in the US were due to stroke (Roger, Go et. al., 2011a). The actual
number of deaths from stroke fell 18.8% from 1997 to 2007 in the US (Roger, Go
et. al., 2011 a), likely due to an increase in controlling some of the major risk

factors. However, the reduction in mortality due to stroke may result in an
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increase in the number of individuals living with the long-term complications of
the disease. Stroke incidence remained relatively stable in the 1990s. However,
since then data have shown that the incidence in stroke is declining in the white
population, but not in blacks (Roger, Go et. al., 2011a). It is estimated that every
year 55,000 more women than men suffer from a stroke (Roger, Go et. al.,
2011 a).

2.2. Stroke Etiology
Stroke is a clinical syndrome caused by a disruption of blood flow in the
brain resulting from either a blockage in a blood vessel (ischemic stroke) or a
rupture in a blood vessel (hemorrhagic stroke) (Mackay J., 2010). Bleeding in the
brain (hemorrhagic), which damages surrounding tissue, or a blockage in a blood
vessel in the brain (ischemic) which reduces blood flow, causes brain cell death
resulting in stroke or a "brain attack". Some cells permanently die, and others are
at risk of death, but may be saved if treated quickly (NINDS, 2011). It is
estimated that 80-87% of all strokes are due to embolism (ischemic), 10% are
due to intracerebral hemorrhage, and 3% are caused by subarachnoid
hemorrhage (Demaerschalk, Hwang & Leung, 2010a; National Institutes of
Health, NINDS, 2007; NINDS, 2011; Roger, Go et. al., 2011a; Roger, Go et. al.,
2011 a).
Common symptoms of stroke include: sudden numbness or weakness
particularly on one side of the body; sudden confusion or problems speaking or
understanding speech; sudden vision impairment; sudden dizziness, trouble
walking, or loss of balance; and/ or sudden severe headache (NINDS, 2011). In
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many cases, more than one of these symptoms will be experienced at one time.
Evidence suggests that the best chance to reduce permanent injury due to stroke
is to seek medical assistance immediately (Demaerschalk, Hwang & Leung,
2010a; NINDS, 2011).
Incidence and mortality from stroke have declined greatly since the 1960's
with the increased understanding and treatment of risk factors and improved
clinical intervention for stroke (NIH - NINDS, ). However, stroke remains the
number one cause of serious disability in adults in the US today (NINDS, 2011).
Currently there is only one US Food and Drug Administration (FDA)
approved treatment for ischemic stroke, intravenous infusion of recombinant
tissue plasminogen activator (rt-PA) (Adams, del Zoppo et. al., 2007;
Demaerschalk, Hwang & Leung, 2010a). This treatment has been shown to
improve neurologic recovery after ischemic stroke and reduce the incidence of
impairment and disability (Adams, del Zoppo et. al., 2007). In contrast, except for
some surgical cases, there is no currently available clinical intervention for
hemorrhagic stroke. In this study, I have elected to focus on ischemic stroke
because there is current treatment for ischemic stroke and evidence suggests it
is a likely contributor to reductions in mortality with subsequent increases in
morbidity.
2.3. Recurrent Stroke
The risk of stroke also increases greatly once a person experiences a first
stroke. Data from meta-analyses suggest that the short-term risk of recurrent
stroke is -3-10% two days after initial stroke and 9-170/0 at 30 days after initial
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stroke (Giles & Rothwell, 2007; Wu, McLaughlin et. al., 2007). Brown et al. found
that 2.5% of stroke survivors will experience a second stroke within one month of
the initial stroke, 6.60/0 will experience a second stroke within six months and
11.8% will experience a second stroke within 12 months (Brown, Lisabeth et. al.,
2005). Despite the high likelihood of recurrent stroke, many individuals with a

history of stroke frequently continue unhealthy lifestyles thereby increasing their
risk of recurrent stroke (Cheng, Jolly et. al., 2005; Hoenig, Nusbaum & BrummelSmith, 1997; Qureshi, Suri et. al., 2001).

2.4. Stroke Risk Factors
The major risk factors associated with stroke include: high blood pressure,
atrial fibrillation, high cholesterol, smoking, poor diet, obesity, family history, lack
of exercise, diabetes, and age (Mackay J., 2010; NINDS, 2011). Risk factors for
stroke include both modifiable and non-modifiable factors. Non-modifiable risk
factors which cannot be changed by an individual include gender, with women
having a higher lifetime risk of stroke than men, due mostly to their longer life
expectancy. An additional non-modifiable risk factor is age. The risk of having a
stroke increases greatly with age. Another is race, with minorities having higher
risk of stroke. An individuals' risk of having a stroke also increases if they have
recently experienced a transient ischemic attack (TIA) (Roger, Go et. al., 2011 a).
Individuals with a history of TIA have a 10 year risk of stroke of -20% (Clark,
Murphy & Rothwell, 2003).
Additional risk factors for stroke that are non-modifiable but in themselves
may be modifiable with behavioral changes or medication use include: increased

12
risk if a person has a history of congestive heart disease, heart failure, peripheral
artery disease, hypertension, diabetes, atrial fibrillation, sickle cell disease, and
dyslipidemia (Roger, Go et. al., 2011 a). The list of modifiable risk factors is
similar to risk factors for other chronic diseases. They include obesity, smoking,
and physical inactivity (Roger, Go et. al., 2011 a). Of these risk factors, having
recently had a TIA, having high blood pressure (hypertension) or having atrial
fibrillation has been shown to carry the greatest increased risk for stroke (Roger,
Go et. al., 2011 a). Stroke risk factors become comorbidities which contribute to
long and short term negative outcomes and cost of care for individuals with
stroke.

2.5. Stroke Mortality
In a study of people

~

65 years of age from Medicare data, the 1-month

case fatality rate was 12.6% for all strokes, 8.1% for ischemic, and 44.60/0 for
hemorrhagic (Roger, Go et. al., 2011 a). Mortality rates due to stroke are higher in
women than men, and in blacks versus whites while risk of stroke increases with
age (Roger, Go et. al., 2011 a). When compared with the Northeastern US, the
crude and age-standardized total and ischemic stroke death incidence rates are
higher in the Southeast and Midwest (Roger, Go et. al., 2011a).

2.6. Stroke Impairment and Disability
The US National Institutes of Health (NIH) estimates that 10 % of people
recover almost completely after stroke, 25% recover with mild impairment, 40%
live with moderate to severe disability requiring special care, 10 % are disabled
enough to require long-term institutionalization, and 15% die shortly after having
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stroke (National Institutes of Health, NINDS, 2007). This equates to over 65% of
stroke sufferers needing specialized stroke-related rehabilitation services. The
need for these services increase costs in individuals with stroke.
The World Health Organization (WHO) in collaboration with the Center for
Disease Control (CDC) publishes data related to the impact of stroke on disability
adjusted life years (DALYS). In these publications they define DAL YS as the
"combined years of potential life lost due to premature death with years of
productive life lost due to disability" (Mackay J., 2010). In the most recently
published version of the CDC and WHO's combined report entitled "The Atlas of
Heart Disease and Stroke", it is estimate that 8 DALYS per 1000 population in
the US are lost due to stroke (Mackay J., 2010).
According to the AHA, based on 2005 Behavioral Risk Factor Surveillance
System (BRFSS) data only 30.70/0 of those surviving a stroke receive outpatient
rehabilitation services. The authors of this AHA report entitled, "Heart Disease
and stroke Statitistics - 2011 Update" suggest that these 2005 findings indicated
that,

"the prevalence of stroke survivors receiving outpatient
stroke rehabilitation was lower than would be expected if
clinical practice guideline recommendations for all stroke
patients had been followed" (Roger, Go et. al., 2011 a).
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In a 2003 study of ischemic stroke survivors who were

~

65 years of age

(based on Framingham Study data) there are a number of disabilities commonly
seen after stroke. This study found that at 6 months following ischemic stroke,

500/0 of their sample had some amount of hemiparesis, 460/0 experienced
cognitive deficits, 35% had symptoms of depression, 30% were unable to walk
unassisted, 260/0 were dependent in activities of daily living (ADLs: Barthel < 60),
26% were institutionalized in a nursing home, 19% had aphasia, and 15% had
sensory deficits (Kelly-Hayes, Beiser et. al., 2003). All of these proportions were
shown to be clinically and statistically significantly greater than seen in a control
group, indicating a need for long-term rehabilitation therapy to address these
deficits and improve symptoms.
2.7. Cost of Stroke in the US

In 2010, it is projected that stroke related costs will reach an estimated
$73.7 billion in the US alone (CDC, 2009). The AHA estimates total stroke costs
in 2007 dollars (from Medical Expenditure Panel Survey (MEPS) data) at $40.9
billion (Roger, Go et. al., 2011 a). The variation between the Centers for Disease
Control (CDC) and AHA estimates, even with a time differential of three years, is
extremely broad. According to the Rochester Stroke Study, the thirty day postevent cost of a mild versus severe ischemic stroke was estimated at $13,019 and
$20,346, respectively (data was from between 1987 and 1989 and severity was
based on Rankin Scores) (Roger, Go et. al., 2011 a). These studies highlight the
need for more consistent and accurate estimates of costs of illness. These cost
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estimates also did not differentiate between stroke-related costs with that of care
for unrelated illnesses.

2.8. Stroke in South Carolina Stroke Belt
Since the 1940s there has been a significant geographic disparity in stroke
mortality in the US, with higher rates seen in the southeast. This area is referred
to as the "stroke belt". The National Heart, Lung and Blood Institute (NHLBI)
identified eleven US states (Alabama, Arkansas, Georgia, Indiana, Kentucky,
Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Virginia)
with stroke death rates that were estimated at 10-200/0 higher than the US
average (National Heart Lung and Blood Institute, 2009; Roger, Go et. al.,
2011 a). Ten of the 11 states cluster in the southeastern US ,and are designated
the "stroke belt" because of their higher incidence of stroke and stroke-related
deaths (Casper, Wing et. a/., 1995; Howard & Howard, 1995; Howard, Evans et.

a/., 1995). The AHA lists only eight states to be members of the stroke belt,
including North Carolina, South Carolina, Georgia, Tennessee, Mississippi,
Alabama, Louisiana, and Arkansas (Figure 2-1.) (Roger, Go et. al., 2011a).
South Carolina has one of the highest stroke mortality rates (130 per
100,000) in the US and is considered to be a member of the Stroke Belt (SC
Office of Chronic Disease Epidemiology and Evaluation, 2009). South Carolina
and specifically Charleston, lies in the "Low Country" or low-lying coastal plains
of SC which has the distinction of being part of the "stroke buckle" where stroke
rates are the highest in the US (Howard & Howard, 1995). Other states included
in the stroke buckle are North Carolina and Georgia. The mortality rate from
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stroke in this region is estimated to be 400/0 higher than in the US in general
(Howard & Howard, 1995). Also notable is a recently published report that
indicates that South Carolina is one of 15 different states that has been defined
as the "diabetes belt" where approximately 12% of residents have diabetes
compared to 8.5% of the rest of the population (Barker, Kirtland et. al., 2011).
Diabetes is a major risk factor for stroke.

Figure 2-1.Age-adjusted Stroke Death Rates by State (Roger, Go et. al., 2011 a).
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2.9. Rehabilitation for Stroke
Post-stroke rehabilitation services are needed to help improve functional
limitations caused by debilitating illness. However, the timing and amount of
services that are needed and for which population groups is not well understood.
Nor is there a good understanding of what is being done in current practice and
how much the current practice of rehabilitation after stroke is costing insurers and
society as a whole. Quantifying current practice patterns and economic cost of
rehabilitation care is essential in order to tackle the questions of "who, what,
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when, and how much is optimal" and for which patients. Without a baseline of
current post-stroke rehabilitation practice patterns and an understanding of
variability in care, the direction that research needs to take to support evidence
based practice in rehabilitation science is unknown.
Rehabilitation use in stroke is an important and complex issue because it
affects both health and costs in a interactive manner. Current rehabilitation
practices are well described in an article by Conroy and colleagues entitled,
"Hospital-Based Stroke Rehabilitation in the United States" (Conroy, Dejong &
Horn, 2009). Once stroke patients have stabilized during acute hospitalization,
they are usually discharged either to home where they often get either homebased or outpatient rehabilitation services, to a skilled nursing facility (SNF), also
traditionally known as a nursing home, if they need more around-the-clock
nursing care, or most commonly to an inpatient rehabilitation facility (IRF)
(Conroy, Dejong & Horn, 2009). Each of these options will allow for a mix of
standard rehabilitation services including, physical therapy (PT), occupational
therapy (aT), or speech language pathology therapy (SLP).
Conroyet. al. indicates the driver of rules for rehabilitation after stroke is
Medicare, because stroke is a low incidence disease that primarily occurs in the
elderly. Since Medicare is the main mechanism funding healthcare for seniors
and the disabled, it covers most people who have suffered a stroke (Conroy,
Dejong & Horn, 2009). Furthermore, rules set by Medicare, both for clinical as
well as time-line and financial requirements are usually adopted by other
insurers.
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The paper by Conroy and colleagues emphasizes the post-acute
rehabilitation practices in IRFs. The average length of stay in an IRF is 15 days,
with 70% of stroke patients being discharged home after their stay and 30%
returning to acute care settings or to SNFs (Conroy, DeJong & Horn, 2009).
SNFs generally provide 24 hour nursing care and 1 to 1.5 hours of PT, OT,
and/or SLP therapy Monday through Friday. Medicare only pays for the first 100
days in a SNF, after which, if additional care is needed, the individual is either
switched to Medicaid or private insurance whom Conroy notes do not generally
cover rehabilitation services.
According to the rules of Medicare, an individual who has had a stroke
and is in an acute care setting would be evaluated based on the "3 hour rule" for
admission to an IRF. Under this rule, a patient has to either already be able to
tolerate 3 hours of therapy (consisting of OT, PT, or SLP) a day or will soon
reach that level of ability in order for the patient to be considered for transfer to
an IRF. The rules for admission to an IRF and rehabilitation requirements once in
an IRF are significant, resulting in limited access due to perception of need,
chances for improvement, and likelihood of discharge to home.

2.10. Evidence for Rehabilitation Services Effectiveness
A consensus group from the American Heart Association published a set
of comprehensive guidelines outlining recommendations for evidence based
acute and post-acute stroke rehabilitation suggested that the strongest evidence
exists to support the use of a well-organized, multidisciplinary team approach to
post-stroke rehabilitation care (Duncan, Zorowitz et. al., 2005). They also
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recommended that rehabilitation be started by the patient as soon as was
medically possible or "early intervention" to facilitate positive outcomes. Although
this group indicated a lack of consistency in defining or testing what "early
intervention" really means. They commented that "current literature is too limited
to allow an assessment of the relationship of specific types of non-inpatient
rehabilitation services after stroke and functional outcome" (Duncan, Zorowitz et.
a/., 2005).

The AHA consensus group gave a series of recommendations for
practices that have been shown to improve a standard set of outcomes,
including: functional status (including the FIM, ADLs and IADLs), rehospitalization rates, community dwelling status, and mortality (Duncan, Zorowitz
et. a/., 2005). In addition to the strong recommendation to offer all stroke patients
organized, multidisciplinary team-oriented stroke unit care, the group gave many
more specific recommendations. The guidelines included, utilization of the
National Institutes of Health Stroke Scale (NIHSS) to assess stroke severity over
multiple occasions, provision of early initiation of rehabilitation therapy, use of
subcutaneous low-dose unfractionated heparin to prevent DVT/PE for patient
with ischemic stroke and impaired mobility, assessment of all patients for
swallowing (dysphagia) impairments, evaluation of all patients for proper nutrition
and hydration, assessment of pain, assessment of all patients for cognitive and
communication impairments, assessment of all patients for psychosocial
problems particularly depression, assessment of all patients for ADLs and IADLs
prior to discharge from acute settings, access to long term rehabilitation care for
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patients where need is indicated except for where poor prognosis for functional
recovery suggest discharge to SNF is preferable (Duncan, Zorowitz et. a/., 2005).
A second group published a recommendation for best post-acute stroke
rehabilitation upon reviewing the structure, process, and outcomes comparing
different international systems of care (Donabedian, 1988; Teasell, Meyer et. al.,
2009). Teasell and colleagues noted that structures of care, such as use of
specialized interdisciplinary stroke rehabilitation units and outpatient care
programs have been shown to impact the process of care, but not stroke
outcomes directly (Teasell, Meyer et. al., 2009). They indicate that there is good
evidence supporting the direct influence of processes of care on stroke outcomes
related to changes in Functional Independence Measurement (FIM) scores,
Length of Stays (LOS), mortality, and discharge destinations. They used the
comparison between westernized countries as a mechanism to differentiate
which process differences may positively or negatively impact overall outcomes,
a similar method as is used in studies of small area variation, but on a large
system scale.
The four processes that were specifically highlighted by this group are: 1)
early time to admission into a stroke rehabilitation unit or program, 2) intensity of
therapy over a shorter time period performing beUer than less intense therapy
over a greater time period, 3) utilization of task-specific therapy being superior to
restorative therapy, and 4) discharge planning being key to improved Activities of

,
Daily Living (ADL) and patient satisfaction, particularly early supported discharge
programs (ESD) for patients who have had mild to moderate strokes (Fisher,
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Gaynor et. a/., 2011; Teasell, Meyer et. a/., 2009). Rehabilitation for individuals
with stroke has the potential to mediate costs due to stroke in the long term.
However this might necessitate an increase in therapy utilization and intensity of
treatment which may require increases in spending in the short term to gain
savings in the longer-term.

2.11. The Economics and Utilization of Rehabilitation after Stroke
Stroke imposes a considerable economic burden on the US healthcare
system, particularly ischemic stroke which accounts for 870/0 of stroke
(Demaerschalk, Hwang & Leung, 2010b). In 2010, it was projected that stroke
related costs would reach an estimated $73.7 billion in the US alone (CDC,
2009), which is a significant increase from the 2008 estimate of $65.5 billion
(Adams, del Zoppo et. a/., 2007). Hospitalization costs from stroke in SC were
estimated at $499 million in 2008 (SC Office of Chronic Disease Epidemiology
and Evaluation, 2009) with additional indirect costs due to lost productivity to be
estimated at another $190 million (Mackay J., 2010).
Healthcare costs continue to rise and are becoming a larger portion of the
national gross domestic product. These costs have become a burden on the
overall economic wellbeing of the nation resulting in more governmental policies
aimed at healthcare cost-containment. The problem with these policies is their
intent may not result in savings but in greater cost burdens in the longer-term as
well as reductions in the quality of care. In a healthcare system as complicated
as what we have in the US, anyone change can have many unforeseen
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consequences that are often not understood until a significant negative impact is
felt.

2.11.1. Cost of Stroke Rehabilitation
Previous studies estimating the cost of stroke have reported widely
varying results. Costs likely differ depending on many factors, including the
amount of rehab care given. Factors that may influence hospital length of stay
and consequently cost of stroke include the type of stroke, stroke severity, and
unmeasured comorbid conditions related to overall health status. What is missing
from this literature entirely is an examination of the cost-effectiveness of different
types of post-acute rehab care. This type of analysis can tie in the pragmatic cost
with patient outcomes. This research is missing because the research community
must reach a point of understanding how "gold-standard" post-stroke
rehabilitation care is defined. Only then can different therapies be compared in
their pragmatic cost-effectiveness to society. It is this great unknown in postacute stroke care that is limiting the direction of research to improve long-term
outcomes in this population.
Post-acute care (PAC) settings include inpatient rehabilitation facilities
(IRFs), skilled nursing facilities (SNFs), home-based healthcare services from
home health agencies (HHA), and hospital-based outpatient rehabilitation
services (ORS). Medicare spending for post-acute care was estimated to
encompass 15% of all Medicare spending in 2008 (Medicare Payment Advisory
Commission (MedPAC), 2008). According to a study by Buntin et. al. on the cost
and outcomes of post-acute care in Medicare patients after stroke, the cost of
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IRF care after stroke is on average $10,121 per episode higher than SNF care
and $24,219 per episode higher than home-based care (Buntin, Colla et. al.,
2010). These authors also found that IRF care resulted in reduced mortality and
SNF care resulted in increased long-term institutionalization after stroke (Buntin,
Colla et. al., 2010). Therefore, while a number of studies have concluded that
IRF care after stroke leads to better outcomes, these gains come at a
considerably higher cost.
It is unclear if these gains are figments of differences due to disease
severity and if these "proxy outcomes" can be directly related to functional
improvements that are of primary concern in this population. It could be true that
more severely disabled patients with the greatest chance for gains are most likely
to get IRF care and more disability means greater room for improvement. It is
easier to measure the impact of acute in outcomes like length of stay, mortality
status, and discharge disposition. Post-acute outcomes tend to be more difficult
to measure especially in larger populations and over long time periods. It is also
important to separate out the cost of acute care from the cost of post-acute
rehabilitation services. A more complete baseline view of utilization and cost will
help to drive the direction of research needed to help answer some of these
deeper, clinically relevant questions.

2.11.2. Stroke Rehabilitation Utilization
Post-acute care (PAC) includes a wide range of healthcare services that
aim to restore recently hospitalized patients to the highest level of functioning
possible and generally involves rehabilitation. It is estimated that 70% of stroke
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patients use PAC services after acute hospital discharge (Buntin, 2007).
Depending on clinical presentation and/or perception of need and ability to
benefit from PAC, medically complicated patients are discharged to IRFs,
patients with age-related cognitive impairments tend to be discharged to SNFs,
and healthier patients or in some cases patients unable to endure intensive
rehabilitation schedules tend to be discharged home after acute stroke
hospitalization (Buntin, 2007). When patients are discharged from inpatient
stroke care they mayor may not receive additional outpatient rehabilitation
services. Thus, the cost of outpatient rehabilitation services will greatly depend
on prior use of inpatient care and patient's perceived ability to benefit from
rehabilitation services. If no outpatient care is received resulting in immediate
cost savings, long-term residual disability may remain creating greater personal
and societal economic burden.
It is understandable and expected that many clinical factors have an effect
on use of post-acute care services. However, due to the lack of and depth of
clinical research indicating which patient groups would benefit most from PACs
including which types, time frames, and intenSity of services benefits particular
patient groups, many non-clinical factors likely influence who utilizes PAC after
stroke (Buntin, 2007). Studies on access and use have shown that geographic
distance to PAC services strongly influence use, and sex, race, and ethnicity
differentially influence utilization of PACs in stroke populations (Buntin, 2007).
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2.12. The Impact of Healthcare Policy on Stroke
The aforementioned non-clinical influences on the utilization of PACs after
stroke, along with the lack of evidence on the appropriate trajectory of care after
an acute event such as stroke, have led many healthcare policy observers to fear
differential access to PACs. It is also possible that other financial factors
including changes to Medicare payment structures may be influencing access
(Buntin, 2007). Buntin and colleagues provide evidence that support these fears,
by illustrating greatly varying use of IRFs, SNFs, and HHAs between 1997 and
2002 in the US which was a time of changing Medicare reimbursement policies
that included the advent of the prospective payment system (PPS). What does
appear evident is that no matter what the intent of changes to payment policies,
there are always unintended consequences.
Besides the impact of the Medicare PPS on PAC facility usage, which
some suggest was short lived and simply shifted care between different types of
facilities (Buntin, 2007), the federal US Balanced Budget Act of 1997 (BBA 1997)
implemented a cap on outpatient rehabilitation services. The BBA 1997 included
a series of changes in Medicare regulations aimed at cost containment including
a $1,500 annual cap on outpatient therapy services. The cap included an annual
limit of $1 ,500 in occupational therapy service expenditures per Medicare
participant, and a $1,500 cap on combined physical and speech-language
therapy per annum, per participant. These amounts were increased in
subsequent years to reflect inflation. While the original effective date of these
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caps was January 1, 1999, the caps have rarely been in effect or enforced (Table
2-1 ).

-

T a bl e 2 1 Regu Ia t'Ion T·Ime I'Ine 0 f 0 u:ga
t t'len t R e h a bTt
II a t'Ion C aps
Capitation
Year
Outcome
Amount
1998
Law not yet in effect
Implemented but under litigation (not
1999
$1,500
enforced)
2000
Under Moratorium
2001
Under Moratorium
2002
Under Moratorium
2003
$1,590
Effective from September - December
2004
Under Moratorium
2005
Under Moratorium
2006
$1,740
Applied with Exceptions*
$1,780
2007
Applied with Exceptions*
2009
$1,810
Applied with Exceptions*
2008
$1,810
Applied with Exceptions*
2010
$1,860
Applied with Exceptions*
2011
$1,870
Applied with Exceptions*
*Exceptions automatic if a complex condition, other conditions require manual requests

Even though the enforcement of the outpatient rehabilitation services caps
has been in flux since the passage of the BBA 1997, the policy change may have
produced a structural change within the outpatient rehabilitation community in
regards to the amount of hours of services commonly rendered. The influence of
a policy prior to enforcement may be due to the tendency of the healthcare
industry to adjust to major legislation before the legislation takes effect, because
the healthcare system decision-makers anticipate legislative changes and
respond proactively (Schwartz & Mendelson, 1991). This research predicts that
outpatient rehabilitation services utilization and rehabilitation costs went down
after the outpatient rehab caps date, even though beneficiary needs likely
increased. The effect of major federal health care policy changes have been
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seen outside of effective dates in the past, such as with the implementation of the
DRG based prospective payment system in the 1980s and 1990s (Schwartz &
Mendelson, 1991).
2.13. Rehabilitation and Health Services Research
Theoretical models that describe and outline the process of disability
caused by injury or illness allow scientists and clinicians a systematic means to
communicate within and between disciplines. They also allow for greater directed
inquiry into causes of disability and methods to illicit rehabilitation from those
disabilities, as well as into the contributing factors that influence both of these
processes. Over time, models to describe the disease process have changed
and developed as health care practice has advanced and become more
complex. These changes include the potential of system-wide policy changes
and their cost implications as factors that may influence clinical and quality of life
outcomes even though they are external to the patient. The study of the long
term effects of stroke and their cost ramifications would benefit greatly from the
perspectives gained through theoretical modeling.
One of the earliest models that continue to drive health care research
today, "the medical model" includes the central theme of the patient as the
problem, with the central goal to cure the individual. Later rehabilitation models
began to expand on earlier thinking to include personal and societal influences
on health. An early rehabilitation model posed by Nagi expanded the medical
model to include the thinking that biological changes can lead to impairments
which may lead to functional limitations possibly causing disability (NAGI, 1964).

28
Today the rehabilitation model that most researchers agree has the most
applicable themes allowing for the complexities of human health is the
International Classification of Functioning, Disability and Health (ICF). The ICF
allows for multi-directional movement between problems on the functional and
body structure level affecting activity which may influence participation. This
model also accounts for the possibility that each of these stages can be affected
by the outside influences of personal characteristics and environmental factors.

Environmental factors can include governmental or system-wide rules on cost
structure.
In order to expand the medical or rehabilitation models that drive health
care research to find solutions on the individual patient level, to the idea that
population health may be affected by even more outside factors, we can utilize
health services research models to direct structural or process level questions. In
the late 1980s and early 1990s, Avedis Donabedian produced a theoretical
Health Services Research (HSR) model on the relationship between health care
structures, processes, and outcomes (Donabedian, 1988). Structure refers to all
factors that may influence the physical environment or setting of health care
delivery, such as policies and procedures, rules and regulations, buildings and
equipment, and standards for performing interventions. This can range from how
hospital facilities are laid out, to who is available at all times on a stroke team, to
reimbursement practices. Process relates to how care is provided. Process
includes effects of factors such as treatment guidelines, how a referral process is
coordinated, the timing of hospitals' discharge of patients to home care or to
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other post-acute care settings, the type of therapy provided or how much therapy
is given. Lastly, outcomes refer to how endpoints of care are measured,
evaluated, and quantified, which may include patient preferences. Outcomes
refer to both intermediate and ultimate outcomes. Intermediate outcomes include
factors related to resource consumption such as cost, length of stay, or
consumption of specific services. Ultimate outcomes are measures such as
survival, quality of life, and health status. The model proposed by Donabedian is
especially useful for organizing factors that related to a "health production"
function, where the focus is on better understanding the effects of structural
constraints, such as regulation, on the utilization of scarce resources, and on
both intermediate and ultimate population outcomes. This model is not as well
suited if the outcomes of interest are related to individual patients, but it is very
accommodating of policy questions.
This research project used the Donabedian "Structure-Process-Outcome"
HSR model as a framework for examining the effect of outpatient rehabilitation
caps on the use of PT, OT, and SLP healthcare services (aim 1). The cap placed
on outpatient rehabilitation services under the BBA of 1997 forces a process
change in the care of patients with stroke. Legislative reimbursements limits fit
the Donabedian model as a structure effect which may be expected to affect the
process of rehabilitation care. This process change will affect the outcome
measured as healthcare cost and also other outcomes such as quality of life
which is not examined in the proposed research. The theoretical framework that
guided this research study is depicted in Figure 2-2 below.
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Figure 2-2. Applied Donabedian Structure-Process-Outcome Model
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Structural changes in rehabilitation practices prompted by the Medicare
reimbursement policy that occurred via the BBA of 1997 with the onset of
outpatient rehabilitation caps fits well into Donabedian's paradigm that
operationalizes constraints on practice settings in the healthcare system and
their effect on the process of care. If rehabilitation practitioners expect to have
limits on the reimbursement for the amount of care that they can administer to a
Medicare beneficiary, it is conceivable that these limits may precipitate a change
in the process of care, including a decrease in average rehab utilization.
Additionally, if utilization is reduced due to changes in the process this may
similarly affect the cost of care which is an economic outcome under the
Donabedian model.
2.14.

Summary

Stroke is a serious, prevalent, disease that is costly to society. Since
stroke mortality is decreasing across the US but individuals are living longer after
stroke, it is reasonable to conclude that long-term morbidity due to stroke is likely
to increase, especially in SC where stroke incidence is high. With increases in
people suffering from the long-term effects of stroke, quantifying rehabilitation
services costs and utilization will help policymakers to plan for future needs and
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will begin to progress our understanding of best rehabilitation practices and
future research needs.
Studies examining rehabilitatjon services utilization can benefit from the
use of theoretical rehabilitation and health services models. These models can
help to outline how structural changes in the healthcare system may influence
processes and in turn healthcare outcomes. Federal regulatory caps on Medicare
reimbursement of rehabilitation services are structural changes that may have an
effect on health services utilization which lies in the area of process of care. The
change in the amount of rehabilitation services received by an individual may, in
turn, affect the cost of care, an economic outcome. In this study theoretical
models were used to map the potential impact of the SSA of 1997 on
rehabilitation services utilization and the related impact on the outcome of stroke
and rehabilitation costs in the year after acute ischemic stroke.

3. METHODOLOGICAL BACKGROUND
It is important to recognize the type of health services research completed
in this project requires a specialized set of methodological approaches in order to
be performed in a reasonable and reliable manner. Challenges related to the
retrospective analysis of long-term administrative billing data include difficulty
specifying diagnoses, procedures, comorbidities, and disease severity.
3.1. Research Using Administrative Data
Administrative data, also known as billing data or archival data, are
commonly used in research to examine health related questions. These data are
readily available, inexpensive to obtain, available in a computer-readable
database format, and cover large populations over long periods of time (Iezzoni,
1997; lezzoni, 1994; Mitchell, Bubolz et. a/., 1994; Zhan & Miller, 2003).
The utility of administrative claims data for the evaluation of health care
services and outcomes has been well established. Over the past 30 years, the
analysis of retrospective administrative data has been used to examine practice
variation (Wennberg et al. 1989; Shwartz, Ash et. al., 1994), determine
differences in access to care in minority groups (Desch et al. 1996), assess
quality of care metrics (Lohr 1990; lezzoni, 1997), estimate incidence of disease
(McBean, Warren, and Babish 1994), and compare surgical outcomes and
disease related outcomes and costs (Lubitz et. a/., 1993). Administrative claims
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data are part of the routine clinical reimbursement of health care services,
allowing for availability of longitudinal data sets, with little cost, and easy
accessibility. The use of these data to answer health services and outcomes
related questions are essential, especially in situations where prospectively
collected data are cost prohibitive or infeasible.
In summary, research designed to measure outcomes and best practices
can be undertaken using inexpensive and efficient retrospective administrative
data analysis. The cost-effectiveness of different post-stroke rehabilitation
programs can be examined using administrative data. Consequently, significant
gains in these previously under examined areas can be achieved in a relatively
short period of time.
3.1.1. Medicare Billing Data

Beginning in the 1980s, researchers began to use administrative data
from Medicare Parts A and B claims, merged on the individual beneficiary level,
to study physician payment issues (Mitchell, Bubolz et. al., 1994). However, it
was not until 1985 that Medicare required providers to utilize a common medical
procedure coding system that is still in use today. Since that time, researchers
have used Medicare claims data to construct episodes of care-based analytical
data files to answer many health services and outcomes related questions
(Mitchell, Bubolz et. al., 1994).
Medicare claims data are currently available in a set of related data files
that are linkable through a non-identifiable unique patient code. This rich source
of data can be used in the evaluation of medical care as these claims include
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information on all services provided to Medicare beneficiaries, including: hospital
events (Part A, including hospitalization diagnoses, procedures, dates, costs
excluding clinician charges and payments, discharge destination, etc.),
supplemental insurance provider files (Part B, including clinician and specialty
charges and payments and their associated diagnostic and procedure codes with
dates of service), nursing home files (including related dates, charges, payments,
etc.), home health service files (including related dates, charges, payments, etc.),
outpatient visit files (including related diagnoses, procedures, dates, charges,
payments, etc.), and durable medical equipment files (including related dates,
charges, payments, etc.). A file commonly known as a "denominator" file is also
included which gives demographic patient information (including age group, race,
gender, and zip code) as well as month and year of death (if applicable). Files to
trace data back to providers are also available. With the recent inclusion of
prescription drug coverage under Medicare Part 0, data files containing
information regarding the use of prescription drug information are promised to be
available in the near future but were not available in the current study's data files.
The Centers for Medicare and Medicaid Services (CMS) require all
providers to submit bills for payment using diagnosis and procedure codes that
are standardized. Outpatient clinical visits are coded using Healthcare Common
Procedure Coding System (HCPCS) which is based on Current Procedural
Terminology codes (CPT). Hospitalization bills are based on diagnosis codes
using International Classification of Diseases, 9 th Revision, Clinical Modification
(ICD-9-CM), although hospital bills will often contain multiple diagnosis (ICD-9-
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CM) and procedure (CPT) codes for each episode (or line item). Since private
insurers tend to follow the lead of CMS, the same coding practices are used for
billing private insurers in the US as well. The ICD-9-CM coding system is also in
use by many countries around the world. In fact, many other westernized
countries have already adopted the next generation of coding, ICD-10-CM, which
is scheduled to go into use in the United States on October 1, 2013.
3.1.2. Reasons to Utilize Medicare data in this Research
The benefits of utilizing billing data for epidemiological, clinical, or health
services research are many; however, researchers must also be aware of a
number of constraints and inherent weaknesses in this type of research. The
positives of these data outweigh the negatives with regard to utilizing
retrospective billing data to answer health services questions. This is particularly
true in studies wishing to answer longer term questions that require cost and
clinical data. This type of research can be very time consuming and costly when
undertaken as a prospective study. Furthermore, in health services research,
medical care practices and policies can change rapidly over time, which make it
difficult to control possible time-related biases even when data is collected
prospectively. Funding for this type of research has historically been limited in the
US which makes the utilization of inexpensive, readily available data even more
valuable to health services researchers wishing to examine healthcare practice
patterns. The strengths of utilizing these readily available retrospective Medicare
billing data sets include:
1. their size, or ability to provide large samples;
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2. their longitudinal nature, or ability for researchers to follow patients
over very long periods of time that are most often contiguous;
3. their availability at little expense; and
4. their representativeness of the population that covers most of the
elderly

(~

65 years of age) and the long-term disabled US

population.
Some constraints of these data include: their lack of coverage of the
privately insured US population; lack of representation in those under 65 years of
age; limitations in the ability of the diagnosis codes to differentiate things such as
initial event or repeat event, side of the body, clinical severity of disease or
condition; and whether or not the event is a comorbidity or a complication of the
condition under study. These data also do not contain other important clinical
characteristics of care that might influence research results such as disease
severity.
Utilizing Medicare data for research purposes can also include a set of
unalterable challenges. One weakness is the variation of provider coding
practices and the fact that coding is done for billing and not expressly for
research purposes. Coding practices also change over time so longitudinal
research based on these data must be done with care and with the awareness
that issues might arise due to these changes. Also, the sheer size of Medicare
data files takes knowledgeable and skilled programmers to properly manage and
organize prior to analysis. Despite the challenges present when using these data,
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utilizing administrative billing data offers the best opportunity to answer the
questions in this study.

3.1.3. Other Sources of Archival Data
Other sources of archival health data include data sets created via
medical record abstraction or via patient derived data (Iezzoni, 1994). Patient
derived data can be collected directly from patients either by interview or survey
and may be retrospective or prospective in nature. Collection of these data can
be time and cost prohibitive. These data are usually limited to clinical information
and generally do not include related costs of care, which is needed to answer the
questions posed in this study.
Some commonly used surveys that are expressly taken for healthcare
research or disease surveillance include national surveys that are done by
governmental or private agencies in regular time intervals. Survey data can be
inexpensive and readily available, however survey data do not usually allow
researchers to follow particular patients over a long period of time and rarely
have cost data included with clinical information. They also tend to be limited by
patient recall and subjectivity. Some examples of survey data sources are: the
National Survey on Drug Use and Health (NSDUH), the BRFSS, the National
Health and Nutrition Examination Survey (NHANES), the Medical Expenditure
Panel Survey (MEPS), the National Health Interview Survey (NHIS), the National
Survey of Sexual Health and Behavior (NSSHB), and the Annenberg National
Health Communication Survey (ANHCS). These data sources have different
associated costs, logistical complications, and feasibility implications (Iezzoni,
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1994}. More importantly, these main sources of survey data all have specific foci,
none of which is amenable to addressing the questions of rehabilitation use and
cost.

3.2. Estimating Cost of Illness
Understanding the cost of an illness is important to help inform decisionmaking related to resource allocation and policymaking, as well as to support
cost effectiveness analysis of treatment interventions (Drummond, Sculpher et.
al., 2005). Governmental planners use disease cost estimates, along with
incidence and prevalence estimates of diseases to help plan for the availability of
budgetary dollars that pay for healthcare services, facilities, and staffing.
There are a wide range of strategies used to estimate disease cost
depending on available data and on the goals of the study. One method begins
by estimating total cost of illness based on ascribing unit cost to estimated
incidence or prevalence rates (Evans, 1990). This method may underestimate
costs because it will miss any effect that a disease may have on other conditions,
such as depression or pain (Luengo-Fernandez, Gray & Rothwell, 2009).
Furthermore, this costing method suffers from lack of evidence gained by use of
patient-level data. Another common method of estimating cost of illness is to
aggregate total direct medical costs on patient level population based data after
an index medical event over a period of time. This is often referred to as "allcause" costing or total healthcare cost. The aggregated "all-cause" costing
approach will likely include health care costs related to any comorbid illnesses
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which are present or arise during the time period, and will therefore tend to
overestimate costs attributable to the disease under study.
This research project uses a third method to estimate cost of ischemic
stroke, marginal cost estimation, which may be expected to more accurately
estimate true cost of care (Luengo-Fernandez, Gray & Rothwell, 2009). Marginal
cost, also known as case-control cost comparison, is calculated by estimating the
costs of resources used for care after an index event, using population based
patient-level data, less the cost of a similar patient population who do not have
the illness, over the same period of time. Arguably, this is one of the more
precise ways to estimate overall cost-of-illness, especially in the case of stroke
where most patients are older and have many comorbid conditions which tend to
increase cost (Luengo-Fernandez, Gray & Rothwell, 2009).

3.2.1. Quality Metrics of Cost of Illness Studies
In an article entitled, "Costs of Stroke Using Patient-Level Data: A Critical
Review of the Literature" by Luengo-Fernandez and colleagues, the authors
specify that there are two ways to derive estimates of cost of illness, either by
expert opinion, or analysis based on patient-level data (Luengo-Fernandez, Gray

& Rothwell, 2009). They based their systematic review search on whether cost
studies on cerebrovascular disease satisfied four criteria that signify quality
research. Estimates based on patient-level data are preferred as they can be
considered evidence based methods. However, all methods utilizing patient-level
data are not equal as far as the validity, reliability, or generalizability of results.
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The first quality metric described in the Luengo-Fernandez review article is
the use of appropriate costing methodologies data (Luengo-Fernandez, Gray &
Rothwell, 2009), and was based on a modified checklist developed by the British
Medical Journal (Drummond & Jefferson, 1996). The authors define appropriate
use of costing methodologies as those that included: whether or not the study
objectives were clearly stated and justified; if the data collection contains
descriptions of unit costs and resource use; as well as, if the methods used were
appropriate; and if the analysis and interpretation of results were reasonable
(Luengo-Fernandez, Gray & Rothwell, 2009).
The second quality research criterion described in this manuscript is
based on if the study sample is representative of the overall population. The third
criterion is concerned with whether or not the study takes into account the
premorbid use of resources (Luengo-Fernandez, Gray & Rothwell, 2009).
Accounting for the comorbidities of patients prior to the indexed illness is
especially important when studying an elderly population since these patients
tend to have a great deal of comorbidities and are more likely to consume a large
amount of healthcare resources in addition to the illness under study. The last
criterion used by these authors to assess study quality is whether or not the
researchers report costs while taking into account patient characteristics,
subtypes, severity, and disease etiology (Luengo-Fernandez, Gray & Rothwell,
2009).
During the seventeen year period of the Luengo-Fernandez and coauthors
review of cost of stroke research studies (from 1990-2007), the authors identified
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120 studies that meet their inclusion criteria: inclusion of cerebrovascular
diseases (CVD), published in English, based in westernized countries, resource
use derived using patient-level data, mean or median costs were reported, and
study sample of at least twenty patients (Luengo-Fernandez, Gray & Rothwell,
2009). Of these studies, only 6 compared the costs of cerebrovascular (CV)
patients with those with no history of CV events. Unfortunately, the authors did
not indicate the specific references for these studies and did not provide a metatable of study information. However, they reported that of the economic studies
undertaken during the review time period, very few used appropriate costcomparison techniques, where attributable or associated cost is estimated.
Luengo-Fernandez and colleagues concluded that disease costs
estimates vary considerably based on differences in time periods and follow-up
time horizons, geographic location, results based on charges versus unit cost,
and inclusion of productivity loss costs (Luengo-Fernandez, Gray & Rothwell,
2009). The authors found a 10-fold difference in cost estimates between Eastern
European studies and studies taking place in either the United Kingdom or the
US (Luengo-Fernandez, Gray & Rothwell, 2009). However, differences in cost
estimates within the US were even more disparate. In the 53 studies estimating
stroke costs in the US, a 20-fold difference was found (cost range $7,309 $146,149) (Luengo-Fernandez, Gray & Rothwell, 2009). So while the authors
concur with many of the costing studies, that CVD poses a significant economic
burden to societies, what might be the biggest "take-home" message is that the

42
large variation in estimates may feed into the perception that these studies are
not reliable which may hinder healthcare policy decision making.
In another recent systematic review entitled, "US Cost Burden of Ischemic
Stroke: A Systematic Literature Review", Demaerschalk and colleagues
examined US studies focusing on the cost of ischemic stroke from 1995 to July
2008 (Demaerschalk, Hwang & Leung, 201 Ob). The authors of this study
concluded that most US stroke cost studies focus primarily on short-term costs,
particularly hospitalization. They also noted that no studies were identified where
the cost of rehabilitation care was estimated (Demaerschalk, Hwang & Leung,
2010b). This systematic review article concludes by stressing the need for more
studies that focus on the long-term costs of stroke, particularly rehabilitation
services and indirect costs. They also note that more recent overall cost studies
are needed since most studies that they found were analyzed using 1990s data
(Demaerschalk, Hwang & Leung, 2010b).

3.2.2. Principles of Costing
In a publication by Evans entitled, "Principles Involved in Costing",
suggested that all attempts to calculate cost of illness should be done with care
and take into account four important principal considerations (Evans, 1990). The
first principle of costing that Evans gives is the determination of viewpoint taken
in the analysis. Viewpoints in relation to economic studies can be taken from a
number of perspectives, including those of the patient, hospital, insurance
company, government, or society as a whole (Evans, 1990). Evans differentiates
all analyses of costs to individual entities, such as the patient or the insurer, as
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"financial costs", while costs from the perspective of society as an "economic
cost" (Evans, 1990).
The second principle of costing that Evans stipulates is the differentiation
between direct and indirect costs. He defines direct medical costs as the "value
of resources used to prevent, detect, treat and rehabilitate the health impairment
or its effects"; while indirect costs are defined as "the output lost by patients, their
relatives, and friends because of the impairment" (Evans, 1990). The inclusion of
indirect costs in an economic evaluation of illness may be reasonable if the
viewpoint of the study is from the societal or individual perspective. Otherwise,
the inclusion of costs such as lost productivity may not be important from the
perspective of an insurer or a hospital.
The third, and perhaps most import cost of illness principle, is the value of
average cost versus marginal cost. Evans notes that "the cost of treating
additional patients and the savings available because fewer patients require
treatment cannot, in general, be equated to the average cost of treating existing
patients". He contends that when one measures average cost, included in these
costs are "operating costs" or "overhead costs", such as building maintenance or
administrative staffing, which will occur whether or not a single additional patient
becomes ill. From the perspective of cost-of-illness based on potential benefits of
prevention, average costs will always overestimate the cost of adding one
additional patient or the savings from one less patient because one fewer patient
will not reduce the need to employ custodial or administrative staff or to maintain
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the building. This is the primary reason that marginal costs should be used when
examining most cost of illness questions (Evans, 1990).
The last principle that Evans contends should be well understood prior to
undertaking a costing study, is the value of discounting when costs occur at
different time periods (Evans, 1990). This idea is based on the principle that a
dollar spent today is more valuable than a dollar spent in the future, because the
benefits of spending today will be felt much sooner. Similarly, from today's
perspective, a dollar received today has more value than one received tomorrow.
For this reason, all costing studies that take place or are interpreted from a
perspective of multiple years should undergo discounting, where "future costs
(and benefits) are discounted back to their present values" (Evans, 1990).
Evans offers insightful suggestions about the interpretation and general
value of cost-of-illness studies. He clarifies that cost studies alone do not give
enough evidence to directly guide public policy but provide baseline values
needed to measure changes due to treatment interventions or healthcare system
effects over time. Evidence of the effectiveness or efficiency of a particular
intervention is needed in order to directly guide policy decisions. Incidence-based
cost-of-illness estimates are valuable. However, to gauge the overall economic
impact that a potential program or intervention may have one must consider
outcomes. Other direct benefits of these types of studies include guidance to
planners of future healthcare needs and provision of data for cost-effectiveness
analyses.
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3.3. Accuracy of ICD-9-CM Code Selection
In complex chronic conditions such as stroke, cost and outcomes research
are usually performed using large retrospective administrative databases.
However the utility of using these databases to examine stroke outcomes is
limited by the reliability of administrative coding to correctly identify stroke
patients. The current and most commonly used diagnosis coding mechanism in
the US is the International Classification of Diseases, 9 th revision, Clinical
Modification system (ICD-9-CM) (Rinaldi, Vignatelli et. a/., 2003).
In 2001, Reker and colleagues examined studies from the 1990's that
validated the accuracy of stroke ICD-9-CM codes, finding widely disparate
methods and results (Reker, Hamilton et. a/., 2001). After examining other
studies, Reker, et. AI., proceeded to undertake their own study of the "best" code
group to select, using two strategies: 1) maximization of sensitivity (identification
of patients with new stroke) and 2) maximization of specificity (limiting accidental
inclusion of non-stroke patients) (Reker, Hamilton et. al., 2001). In many cases
only the Positive Predictive Value (PPV) is available in these studies as a
measure of accuracy since many of these studies sample based on a stroke
cohort, which under-represents non-stroke patients.
While the list of general ICD-9 codes for cerebrovascular disease shown
in Table 3-1 (Rinaldi, Vignatelli et. a/., 2003) appear clearly defined, there are
many sources of variation in hospital-specific coding practices, such as intercoder reliability, poor clarity in medical charts, differences in data quality between
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hospitals or healthcare organizations, or lack of precision of the codes
themselves (Rinaldi, Vignatelli et. a/., 2003; Wahl, Rodgers et. a/., 2010).
Table 3-1. ICD-9 Codes for Cerebrovascular Disease
ICD-9 Code
ICD-9 Classification Heading
430.xx
Subarachnoid hemorrhage
431.xx
Intracerebral hemorrhage
432.xx
Other and unspecified intracranial hemorrhage
433.xx
Occlusion and stenosis of precerebral arteries
434.xx
Occlusion of cerebral arteries
435.xx
Transient cerebral ischemia
436.xx
Acute, but ill-defined, cerebrovascular disease
437.xx
Other and ill-defined cerebrovascular disease
438.xx
Late effects of cerebrovascular disease

Additionally, some investigators will specify samples using only the first
three digits in the ICD-9-CM codes and some indicate the need to restrict code
selection to further sub-classification up to the fourth and fifth. Investigators must
also consider whether or not to include diagnosis of stroke from only the primary
diagnosis position in the data set or in the primary and collection of secondary
diagnosis variables.
Extra caution should be taken in studies intending to estimate stroke
incidence or prevalence rates since overestimation is likely to occur (Reker,
Hamilton et. a/., 2001). When using administrative data to estimate incidence and
prevalence using ICD-9-CM codes, it has been well documented that estimates
can vary greatly depending on which codes are included (Reker, Hamilton et. a/.,
2001). Different code sets should be used when deciding which ICD-9-CM
codes are best for estimating disease burden versus if the study objective is to
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garner a patient cohort of individuals who have had a stroke. In the latter case, a
method of specificity and PPV maximization is preferred.
Codes used to select stroke population samples should be well defined.
For example, certain individual codes are reasonable to use if selection of
specific stroke sub-types are intended, particularly those for intracerebral
hemorrhage (431.x), or transient ischemic attack (43S.x) (Reker, Hamilton et. a/.,
2001). However, study findings differ as to the accuracy of the use of ICO-9-CM
code 430.x in correctly identifying patients with subarachnoid hemorrhage
(Kokotailo & Hill, 2005; Leone, Capponi et. al., 2004; Reker, Hamilton et. al.,
2001; Tirschwell & Longstreth, 2002). If researchers have a large population
based database available, and intend to sample a cohort of individuals with

ischemic stroke for analysis of outcomes, the most consistently accurate ICO-9-

eM codes which to use to garner the sample appear to be 434.xx and 436.x
(Reker, Hamilton et. a/., 2001). When the intention is to use a set of ICO-9-CM
codes to correctly identify a "high specificity all strokes" cohort, Reker and
colleagues confirm, in a well-designed large sample study, that codes 431.x,
434.xx, and 436.x in any diagnosis position result in good accuracy (Reker,
Hamilton et. a/., 2001). Thus, when planning research using ICD-9-CM codes to
identify patients with ischemic stroke, where the study question aims to minimize
inclusion of patients incorrectly diagnosed with stroke, using ICO-9-CM
diagnoses codes 434.xx and 436.x in the primary variable field for identification is
best.

48
3.4. Taking into account Comorbidity and Severity of Illness
The importance of appropriately controlling for factors, such as disease
severity and the presence of comorbid conditions when analyzing data from
patients with stroke or other complex chronic conditions is well documented.
Severity and comorbidity measures are used in a variety of situations from
clinical trials, to epidemiologic studies, and cost-effectiveness analysis, where it
is important to be able to control for disease severity in order to properly quantify
the true difference in outcomes between comparison groups. Without accounting
for differences in comorbidities and disease severity when analyzing
retrospective cohort or case-control data, a researcher may not be sure if
differences found between groups are attributable to the problem under study or
are simply due to population differences.
3.4.1. Measuring Comorbidity
There are many indices of comorbid conditions that have been developed
and used for analysis of a variety of health related outcomes. An example of
such an index that was developed to control for comorbid conditions in the
analysis of hospital data is the Charlson Morbidity Index (CMI). The CMI is an
excellent model of the value that an index can provide due to its utility of
controlling for health-related population differences when analyzing
administrative data repositories. The CMI was originally developed to abstract
medical diagnoses from inpatient medical records and combine them into a
single index to be used as an independent covariate in the analysis of hospital
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outcomes and a proxy measure of a patients' 1-year mortality probability
(Charlson et. al., 1987).
Since the development of the CMI, there have been cross-walks from
diagnoses on medical records, to ICD-9-CM diagnosis codes that are available
from hospital billing data (Deyo et al. 1992, Elixhauser et al. 1998). The ability of
the CMI to be translated from its original diagnosis categories and weights, to
ICD-9-CM diagnosis codes, has made it the single most commonly used
morbidity index in the analysis of both prospective and retrospective data for
many different types of disorders and diseases. In contrast, there are no
established indices of stroke severity for use with administrative data. This
project utilized similar principles to cross-walked a set of codes to estimate stroke
severity. This set of codes will be studied in-depth for reliability and validity in
future research.
In a Medline search of research conducted since 1997, the CMI was used
in 573 published research projects to help control for extraneous factors that
might affect the outcomes or costs being studied. In order to assess differences
in groups, all other possible independent factors that may affect the outcome
being studied must be controlled for within the analysis. Severity of illness and
comorbid conditions are the two main factors, outside of demographic
descriptors, that are used to account for these independent predictors of health
related outcomes.
For example, if it is a researchers' goal to estimate the 1-year attributable
cost of a post-stroke condition such as the communication disorder aphasia in
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Medicare patients who have suffered an ischemic stroke using state provided
Medicare hospital billing data, we would need to add up the total costs for each
patient who suffered a stroke in the targeted time period and analyze if the
average annualized health-related cost in the patients who have had aphasia due
to stroke, differs from those who did not have aphasia. In order to be confident
that our cost difference is due to aphasia we would need to make sure that our
two groups, aphasics and non-aphasics, had equal comorbidities as well as
equal stroke severity. If we are not able to control for comorbid conditions and
level of stroke severity, we could not be sure that the cost difference was due to
having aphasia or to one group having poorer health than the other.
3.4.2. Measuring Disease Severity
In complex chronic conditions such as stroke, cost and outcomes research
are usually performed using large retrospective administrative databases.
However the utility of using these databases to examine longer-term stroke
outcomes is limited by the lack of an availability of a stroke severity measure.
This hinders proper evaluation of rehabilitation related outcomes among
individuals varying significantly in severity due to our inability to control for
severity of illness. In order to assess differences in groups, the analysis must
include adjustments for all other independent factors that may affect the outcome
being studied.
In studies involving ischemic stroke related outcomes the most commonly
used severity measures in the United States are the NIHSS or the modified
Rankin Scale (mRS). These scales are inconsistently collected in hospital
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medical records and usually require capture in a systematic prospective manner
in order to be used in clinical trials or other similar studies. Unfortunately even
within the vast amount of retrospective data derived from administrative
databases; there is currently not a good measurement of stroke severity that can
be used as an independent predictor of outcome or as a means for matching
patients.
The development of a stroke severity index that can be derived from
administrative data would allow researchers to answer a vast array of longerterm stroke outcomes and rehabilitation related questions. We could better detect
differences in post-acute access to physical, occupational, or speech-language
therapy programs; answer questions related to predictors of re-stroke; and
compare costs of treatment programs and outcomes among groups with differing
stroke severity. All of these questions could provide the evidence needed to
direct future clinical research questions, resource allocation, and policy decision
making.
Since both an individual's severity of illness and the presence of
comorbidities can potentially influence overall probability of continued morbidity
or death, analyses for patient outcomes research must adjust for these factors to
properly account for variation of health status within patient cohorts. A selection
of codes to use to account for stroke severity in this analysis has been previously
reported in an applied cost of illness study (Ellis, Simpson et. a/., 2012). Based
on an examination of evidence presented in previous research a series of codes
were selected based on their diagnostic relationship with the NIHSS. These
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codes include: dysarthria (784.5), aphasia (784.3), dysphagia (787.2),
hemianopia (368.4x), sensory impairment (782.0), neglect (781.8), memory loss
(780.93), and hemiplegia (342.xx) (Ellis, Simpson et. a/., 2012). These ICD-9-CM
codes were selected for their ability to map back to the key components of the
NIHSS which include: 1) Level of Consciousness, 2) Aphasia Visual Impairments
(hemianopia - partial, complete, bilateral), 3) Facial Palsy, 4) Motor Arm, 5)
Motor Leg, 6) Limb Ataxia, 7) Sensory impairment, 8) Dysarthria, and 9)
Neglect.
Additional diagnoses and procedures with related codes have been used
as factors related to stroke severity in previous studies: 1) mechanical ventilation
(CPT codes 94656, 94657; ICO-9 code 96.7x), 2) placement or revision of a
gastrostomy tube (CPT codes 43750, 43760, 43761, 43832, 43246; ICO-9 code
43.11), 3) hemiplegia and hemiparesis (ICO-9 code 342.xx), 4) residual
neurologic deficits (ICD-9 codes 345.40-345.51 and 345.50-345.91 for epilepsy,
348.1 for anoxic brain damage, 348.3x for encephalopathy, 780.3x for
convulsions, and 784.3 for aphasia) (Smith et al. 2005, Lee et al. 2010).
Current research in the areas of rehabilitation service utilization in stroke
care is limited by the inability to control for stroke severity which will be greatly
enhanced by a well designed stroke severity measure for use in administrative
data. The stroke severity index used in the current research, in combination with
the CMI, will provide the strongest analytical control available for the analysis of
retrospective billing data when looking for differences in stroke-related outcomes.
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3.5. Controlling for Selection Bias
Selection bias is the bias associated with an unbalanced selection of
individuals under study. Szklo and Nieto remark that selection bias is particularly
problematic in case-control studies which is the study designed used for aim 2 of
the current research study. They define selection bias as, " ... a systematic error in
the ascertainment of the study subjects - cases or controls in case-control
studies, ... (that) results in a tendency toward distorting the measures expressing
the association between exposure and outcomes" (Szklo & Nieto, 2007).
The objective of randomization in studies on health is to obtain groups that
are balanced, or comparable, in terms of observed and unobserved group
characteristics. If this balance is not achieved it may not be clear whether a
difference observed on a certain outcome of interest is due to the "treatment"
under study or is the result of underlying differences between the groups. Even in
randomized studies, balance between groups is analyzed for residual bias.
However, when using large retrospective observational data sets to
assess health outcomes, randomization prior to data collection is not possible.
Therefore, other methods, often referred to as "pseudo-randomization methods",
must be used in order to balance groups. One well developed and largely
accepted method to accomplish this task is the utilization of propensity score
techniques.
Propensity Score (PS), as described by the founders of the method,
Rosenbaum and Rubin, is "the conditional probability of assignment to a
particular treatment given a vector of observed covariates" (Rosenbaum & Rubin,
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1983). The first step in using this technique is estimating the likelihood (i.e. the
propensity score) that each individual in the sample would have received "the
treatment" given a set of their personal characteristics. This is done by estimating
the probability of inclusion in the group (i.e. having a stroke) given a set of
covariates, such as age, gender, race, history of hypertension, etc., by using a
logistic regression. Rosenbaum and Rubin stipulate the importance of thinking of
PS methods as a study design tool that approximates randomization, rather than
an analysis tool (Rosenbaum & Rubin, 1983; Rosenbaum & Rubin, 1985; Rubin,
1997).
Once the propensity scores have been estimated for each individual they can
be used in the analysis of interest, i.e. "comparing treatment group effects", in
three different ways: 1) by matching the controls to the cases by similarity in
propensity score, 2) by using the propensity score to stratify the analyses, 3) by
using the propensity score as a covariate in the final multivariable model in order
to control for possible confounding effect. Interestingly, while the third method
has been used by many researchers, it is not the correct way to employ a
technique that was developed to approximate randomization, i.e. garner similarly
balance comparison groups. Controlling for an individuals' likelihood of being in
the treatment group does not ensure that groups are balanced on observed
covariates and is considered an "inferior or mistaken" method to use according to
Donald B. Rubin, a developer of the method (Rubin, 2004). For this reason, only
the first two methods to employ the use of propensity scores in observational
studies will be discussed in the following sections.
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3.5.1. Propensity Score Stratification Methods
The method of stratification by propensity score has been used since the
development of the measure. This is particularly due to the simplicity of
application and the limitation of computing resources in the early years of using
propensity scoring methods in observational research studies. Once the logistic
regression has been used to estimate a propensity score for each study subject,
the most common PS stratification approach takes the range of the propensity
scores from the minimum value to the maximum value and divides it into five
equally sized strata and these strata are then used to match similar controls to
cases (Austin, 2009). Once this stratification variable is developed, it is used as a
continuous covariate in the multivariable analysis of interest along with the
original covariates that were used in the logistic regression model development
of the PS. It has been demonstrated that using this stratification method
eliminates approximately 90% of the bias due to the measured confounders and
is a very good way to control for selection bias caused by observed baseline
characteristics (Rosenbaum & Rubin, 1983).

3.5.2. Propensity Score Matching Methods
One must carefully select a well-matched control group, using proven
techniques, when estimating marginal cost. It is also important to understand why
marginal cost is a superior method to estimate cost of illness when compared to
other costing strategies. Recent studies comparing the ability of propensity score
matching, i.e. matching a case with a control or a number of controls based on
an algorithmic set distance, have indicated a superior ability of propensity score
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matching to balance groups in observational studies, over the older stratification
methodology (Austin, 2009). There are a number of mathematical algorithms with
which matching can be performed with today's computing power, although the
most commonly used is "nearest neighbor matching" using a "greedy algorithm".
Besides deciding which algorithm to use, the researchers must also consider the
structure, i.e. 1 case to 1 control paired matching, 1 case to many controls
matching, or optimal full matching which allows all controls to be matched to
cases but does not ensure an equal number of matched controls to cases (Gu &
Rosenbaum, 1993). The distance metric used between case and control pairing
must also be considered. Lastly, one must also consider if the matching of cases
to controls will be done with or without replacement.
In an applied example comparing propensity score methods, Austin and
Mamdani concluded that using a greedy-match algorithm with caliper distance
set to a maximum width of 0.2 standard deviations of the logit of the estimated
propensity score and a 1 case to 1 control matching scheme, without
replacement, resulted in superior overall performance and eliminated systematic
differences between treatment groups when compared to stratification methods
or using PS as a controlling covariate (Austin & Mamdani, 2006). In a second
theoretical simulation study comparing some of these matching practices, the
authors concluded that a more computationally complex form of optimal
matching, using total distance between all controls to one case, rather than
nearest neighbor matching criterion, did not improve the balance between groups
(Gu & Rosenbaum, 1993). When considering the structure of matching (1 : 1
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versus 1:m versus complete optimal matching), practical considerations are
important when examining whether or not to match controls to cases with or
without replacement. Whether selecting to match with or without replacement of
controls, one must consider the complexity of statistical techniques needed when
using "with replacement" since this creates situations where there are many
within match group dependencies (Austin, 2009).
3.6. Summary
There are methodological issues that must be considered in order to
maximize the potential of the research when utilizing retrospective billing data to
examine HSR questions. A cost and time efficient way to examine health
services utilization and cost of illness is to analyze long-term, readily available
administrative data. Methods to control for population differences, such as
estimating and controlling for comorbidities and disease severity, are essential to
ensure that conclusions reached are valid and unbiased. It is important to choose
procedural and diagnosis codes carefully when constructing cohorts using this
type of data, otherwise individuals may be erroneously included or excluded
which may introduce bias. It is also important to control selection bias by utilizing
techniques such as propensity score matching during analysis of this type of
data.
Calculating the cost of stroke is important to help inform policy decisionmaking for future resource allocation, as well as to support cost-effectiveness
studies. Marginal cost is one of the best methods to calculate cost of illness,
particularly in populations with more comorbidity such as the in elderly. It is
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essential to have a similar comparison group when estimating marginal cost and
the best method for which to garner well matched groups in this type of research
is to use propensity score matching methods.
Therefore, the purpose of this study is to examine the effect of Medicare
outpatient rehabilitation caps enacted in the Balanced Budget Act of 1997 on the
utilization of post-acute stroke rehabilitation services and their associated costs.
This research project also estimated the total versus marginal cost of ischemic
stroke in South Carolina in 2004 and the proportion of those costs that were postacute rehabilitation services related. These estimates provide an important
benchmark for which to compare future estimates and may help provide inputs to
better estimate Medicare funding needs. They also allow healthcare
professionals, researchers, and policymakers to recognize the difference
between estimating the total annual cost of healthcare for patients with an acute
event versus the marginal cost of healthcare due to the acute event. Particularly
in illnesses that predominately occur in the older Medicare population, the
difference between measuring cost of illness as total cost of care versus marginal
will likely be much more extreme than what would be expected in a younger
population that uses fewer healthcare services each year.

4. METHODS
This study was designed to examine the utilization and cost of
rehabilitation services in Medicare patients with ischemic stroke in the state of
South Carolina in order to improve our understanding of:
1) rehabilitation services utilization and cost changes in 1997 versus 2004,
and
2) the 2004 marginal cost of stroke, over and above normal costs expected
in a similar non-stroke population, and the proportion of marginal costs
attributable to rehabilitation.
The aims and hypotheses of this study are as follows:
AIM 1

To examine the cost and utilization of rehabilitation services (PT, OT,
SLP), before and after the 1997 Balance Budget Act.

Hypotheses
H1: Rehabilitation utilization (measured as proportion

TT

over cap) among those

who receive rehab after stroke is greater in 1997 than 2004.

Ho:

TT over cap (provider) 1997

Ha: TT over cap (provider) 1997

=TTover cap (provider) 2004
¢

TT over cap (provider) 2004
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H2: Rehabilitation cost

(fJ

payments) among those who receive rehab after stroke

is greater in 1997 than 2004.
H 0: fJ rehab cost 1997

=

Ha: fJrehab cost 1997

¢ fJ rehab cost 2004

fJ rehab cost 2004

Rationale
It is important to understand the effects of structural changes in
governmental health care spending regulations (therapy caps) on the process of
rehabilitation services utilization and outcome of cost.

AIM2
To determine the cost of stroke-related healthcare and stroke-related
rehabilitation care for South Carolina Medicare patients in 2004 and examine
what proportion of the cost is rehabilitation related.

Hypotheses
H1: The 1-year cost of stroke healthcare services
the cost of care

Ho:

(fJ

(fJ

payments) is greater than

payments) of the matched control Group.

fJ cost of care (2004 stroke group)

Ha: fJ cost of care (2004 stroke group)

= JJ cost of care (2004 control group)
¢

fJ cost of care (2004 control group)

H2: The 1-year cost of rehabilitation services (JJ payments) is greater than the
cost of rehabilitation care

Ho:

(fJ

payments) of the matched control Group.

fJ cost of rehabilitation-related care (2004 stroke group)

control group)

= IJ cost of rehabilitation-related care (2004
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Ha:

I.J cost of rehabilitation-related care (2004 stroke group) ¢ I.J cost of rehabilitation-related care (2004
control group)

H3: The proportion (n) of the marginal cost of stroke that is rehab-related is
greater than the proportion (n) of rehab-related care using total cost of
stroke, in 2004.
Ho: TT marginal rehab-related cost/marginal cost 2004

Ha: TT rehab-related cost/marginal cost 2004

=TT total rehab-related cost/total cost 2004

¢ TT rehab-related cost/total cost 2004

Study Rationale
Cost of illness has been historically reported as direct total healthcare cost
and has never been compared as a marginal cost difference with an equally ill,
non-stroke, control group. Therefore the outcome of cost of illness has been
historically misrepresented in a population that tends to have a great amount of
I

care costs that are related to comorbidities. The over-estimation caused by
estimating cost of illness using t6tal cost of care results in an under-estimation of
the impact and need for stroke rehabilitation.
The primary endpoints that were used to support the examinations of aims
1 and 2 of this research are embedded in an applied theoretical view of the
Donabedian Structure-Process-Outcome model in Figure 4-1 below.
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Figure 4-1. Primary Study Endpoints Related to Theoretical Framework of Aims
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4.1. Study Design
Aim 1 of this study uses a retrospective cohort design where Medicare
beneficiaries with index ischemic stroke in 1997 are followed until death or up
until 1 year after stroke, whichever comes first. The 1997 stroke cohort is
compared with a similarly selected and followed cohort having an index ischemic
stroke in 2004. Aim 2 of this study utilizes a retrospective case-control research
design. SC Medicare data from 2004 are used to select a set of ischemic stroke
cases. Each stroke case is matched with two non-stroke controls from the same
year. Cases and controls are followed for c:t year or until death, whichever comes
first. Matching controls to case is performed using propensity score techniques in
order to control for potential selection bias.
A retrospective longitudinal cohort of patients with a primary diagnosis of
ischemic stroke was extracted from the SC Medicare hospital discharge
Standard Analytic File (SAF) database that contained data for the years 1996,
1997, 1998,2003,2004, and 2005. Aim 1 cohort groups are expressed as the
"early cohort", referring to the group of 1997 ischemic stroke patients, and the
"late cohort" describing the 2004 ischemic stroke patients. Patients were
excluded if their index stroke date did not take place in the appropriate index
year, either 1997 or 2004. Any patients less than 65 years of age at the time of
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the hospital admission for their index stroke were also excluded. Stroke patients
with missing race information or with a primary diagnosis of ischemic stroke that
resulted in hospitalization in the six months prior to index stroke were also
excluded. Lastly, patients who expired while in the hospital for their index
ischemic stroke were excluded.
Ischemic stroke patients were selected from the 2004 Medicare SAFs in a
similar manner in aim 2 as for aim 1. The same exclusions were used in aim 2 as
is described in aim 1 except that individuals who died in hospital for their index
stroke were not excluded in this analysis.
4.2. Data Sources

The data used in this study were provided by the SC Office of Research
Services (ORS) from a state-wide cohort of Medicare participants from SC which
was made available to the researchers as part of the EXCEED grant (South
,

Carolina EXCEED Project funded by AARQ under DUA #16339 EDG#4081) to
examine health disparities in minority populations. This study has been reviewed
and approved by the institutional review board for human subjects at the Medical
University of South Carolina.
The current research project utilized six years worth of data, spanning a
ten year time period, of administrative Medicare billing data. SAFs include data
collected by the Centers for Medicare and Medicaid Services regarding charges
and payments for health care services provided to Medicare beneficiaries.
Medicare SAFs include two sets of files used by providers for billing; durable
medical equipment (DME) and part B provider bills (also known as carrier files),
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and five facility billing files including; inpatient, outpatient, home health, skilled
nursing, and hospice (ResDAC, 2011). Since spending in hospice was negligible
and utilization of rehabilitation in hospice does not generally occur, this file was
not used in this study.
Provider billing includes DME claim files that include final action claim data
submitted to Medicare by durable medical equipment suppliers. Part B provider
billing files also fall under provider billing. They contain final action claims data
submitted by non-institutional providers. Examples of part B providers include;
physicians, physician assistants, social workers, nurse practitioners, independent
clinical laboratories, ambulance providers, independent physical and
occupational therapists, and free-standing ambulatory surgical centers (ResDAC,
2011 ).
Facility billing includes final action claims data submitted to Medicare from
inpatient hospital providers and skilled ~ur.sing facilities for reimbursement of
facility costs. Facility costs can include services provided by clinical providers
who are employed by the facility. Home health agency (HHA) claims file contains
data submitted by HHA providers. Facility billing also includes outpatient claims
files which contain final action claims submitted by institutional outpatient
providers such as; hospital outpatient departments, rural health clinics, renal
dialysis facilities, outpatient rehabilitation facilities, comprehensive outpatient
rehabilitation facilities, and community mental health center (ResDAC, 2011).
This type of data has been widely used by researchers to study outcomes,
epidemiology, and health services rates of utilization among elderly and
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permanently disabled patients in the US. SC Medicare data from hospital, home
health, outpatient, skilled nursing, durable medical equipment, and Part B
provider files were merged together and linked using encrypted beneficiary
identification numbers. Costs for each patient were aggregated over the study
time period.
4.3. Measurement of Variables
Appendix A provides an overview of the variables supplied in the original
Medicare data, as well as derived variables that were used in this study. Some
important variables that were derived for this research, include indicator variables
of "early" (1997 index stroke) or "late" (2004 index stroke) stroke cohort (aim 1),
case versus control group indicator (aim 2), and indicator of being over or under
the outpatient rehabilitation services cap enacted in the BBA of 1997 (aim 1).
To classify stroke severity, a proxy index of severity for administrative data
was created using the same criteria thatis .described in previously published
research (Ellis, Simpson et. al., 2012). Stroke severity was defined as mild if
patient had no major stroke-related diagnoses (aphasia, dysarthria, dysphagia,
sensory impairment, hemianopia, neglect, memory loss or hemiplegia) during
index hospitalization, moderate if at least one stroke-related diagnosis was coded
(excluding hemiplegia), and severe if hemiplegia or two or more stroke-related
diagnoses were coded.
4.4. Data Set Construction: Aim 1
Beneficiaries' data were linked from different claims files via encrypted
beneficiary identification numbers at the individual level and followed
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longitudinally in two groups. The first cohort included patients who had a primary
diagnosis of acute ischemic stroke requiring hospitalization in 1997 and the
second cohort of patients included those diagnosed with a primary ischemic
stroke in 2004 that required hospitalization. Each cohort was followed for the
remaining time period of available data. The six months prior to stroke for each
cohort was used to construct the Charlson comorbidity Index up until and
including index stroke for each patient and were also used to exclude individuals
with previous ischemic strokes. This ensures that the index stroke is not a recent
re-stroke and provided a clearer cohort of incident ischemic stroke sufferers with
a well-defined comorbidity measurement.
The patient population of interest in this study includes patients
hospitalized with newly diagnosed acute ischemic stroke in either the year 1997
or 2004. Patients were selected based on the presence of a primary diagnosis of
,
".

AIS via the most consistently accurate and highly specific ICO-9-CM codes of
434.xx or 436.x in the hospital impatient claims file (Reker, Hamilton et. a/.,
2001). Patients were excluded from the cohort if they met the following exclusion
criteria: not enrolled in Medicare in 1996 or 2003, less than 65 years of age,
indication of previous stroke, not having at least one physician claim in the year
following stroke unless discharged dead during index hospitalization, or if race
data is missing.
The two groups were then be used to compare early (1997) versus late
(2004) rehabilitation services utilization and cost of physical therapy (PT),
occupational therapy (OT), and speech or swallowing therapy (SLP). Billing
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codes were used to identify indicators of rehabilitation use (Appendix B), stroke
severity, and comorbid conditions.
ICD-9-CM diagnosis, Healthcare Common procedure coding system
(HCPCS), and CPT codes were used to identify indicators of rehabilitation
services use. The following table (Table 4-1) discussed by Zorowitz and
colleagues, outlines codes that have be used in a past study to define general
indicators of rehabilitation therapy services use (Zorowitz, Chen et. al., 2009) and
were used as an initial starting point to help designate rehabilitation use.
Table 4-1. Zorowitz et. AI. Rehabilitation Code Selections
Settings
Code
Code
Description
Type
Hospital Inpatient

Hospital outpatient
and primary care

ICO-9CM
DRG
CPT

V57xx
462
92506,92507,
92508
97001, 97002,
97003, 91004,
97010-97039-

97110-97546
97703,S7750
97780, 97781,
97799

Skilled Nursing
Facilities

HCPCS

G0129

ICO-9CM
ICO-9CM
RUG

V57xx
V57xx
First three digits:
FHA, FHB, RHC,
RLA, RLB, RMA,
RMB, RMC
RUA, RUB,

Care involving use of rehab.
procedures
Rehabilitation
Evaluation or treatment of speech,
language, voice, communication
and/or auditory processing
Physical therapy evaluation
Occupation therapy evaluation
Application of a modality to one or
more areas including, but not limited
to thermal, acoustic, light mechanical
or electric energy
Therapeutic procedures one or more
areas
Tests of measures of physical
performance
Other physical medicine/rehabilitation
services/procedures
Occupational therapy requiring the
skills of a qualified occupational
therapist, furnished as a component of
a partial hospitalization treatment
program, per day
Care involving use of rehab.
procedures
Care involving use of rehab.
procedures
Low/medium/high rehabilitation

Very high/ultra high rehabilitation
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Home Health Agency

HCPCS

RUC, RVA,
RVB,RVC
G0151-G0153

S8990

ICO-9CM

S9128, S9129,
S9131
V57xx

Physical, occupational, speech and
language in home health setting (each
15 minutes)
Physical or manipulative therapy
performed for maintenance rather
than restoration
Speech, occupational, physical
therapy at home iPer diem)
Care involving use of rehab.
Qrocedures

This project examined outpatient billing for PT, OT, and SLP services due
to the potential effects of SBA of 1997 caps specifically on these services. The
following is a list of CPT codes commonly used by these service groups (Table 42). To distinguish between the service type, Medicare requires these billing
codes be entered with the modifier "GN" for services delivered under an
outpatient speech-language pathology plan of care; "GO" for services delivered
under an outpatient occupational therapy plan of care; or, "GP" for services
,.,

delivered under an outpatient physical therapy plan of care. These modifiers
were found in 2004 date but did not exist in years before the SSA of 1997 was
enacted, and was therefore not available in 1997. Outpatient rehabilitation
--

modifier codes were used to help designate line items in 2004 data but were
found to be little used. Therefore, rehabilitation codes were also used to define
line item bills as rehabilitation-related even if they did not have modifier codes
attached. A list of all rehabilitation codes used to define rehabilitation line items is
included in Appendix B.
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Table 4-2. Outpatient PT, OT, and SLP Billing (CPT or HCPCS) Codes
Clinical Service

SLP

Codes
92506
92507

92508

92526
92610
92626
92627

PT

97001
97002
97110

97112

97116
97124
97140

97150
OT

97003
97004
97140
97535
G0129

G0152

G0160

S9129
G0158

Description
Evaluation of speech, language, voice,
communication, and/or auditory processing
Treatment of speech, language, voice,
communication, and/or auditory processing disorder;
Individual
Treatment of speech, language, voice,
communication, and/or auditory processing disorder;
group, 2 or more individuals
Treatment of Swallowing dysfunction and/or oral
function for feeding
Evaluation of oral and pharyngeal swallowing function
Evaluation of auditory rehabilitation status; first hour
Evaluation of auditory rehabilitation status; each
additional 15 minutes (List separately)
Physical TheraQY Evaluation
Physical TheraQY Re-evaluation
Therapeutic procedure, one or more areas, each 15
minutes; therapeutic exercises to develop strength
and endurance, range of motion and flexibility
Neuromascular reeducation of movement, balance,
coordination, kinesthetic sense, posture, and/or
proprioception for sitting and or standing activities
Gait Training (includes stair climbingl
Massage, including effleurage, petrissage and/or
tapotement (stroking, compression and percussion).
Manual Therapy Techniques (eg.
mobilization/manipulation, manual lymphatic drainage,
manual traction), one or more regions, each 15
minutes
Therapeutic procedure(s), group (2 or more
. individuals).
Occupational Therapy Evaluation
Occupational Therapy Re-evaluation
Manual therapy
Self-care management training
Occupational therapy requiring the skills of a qualified
occupational therapist, furnished as a component of a
partial hospitalization treatment program, per day
Services performed by a qualified occupational
therapist in the home health or hospice setting, each
15 minutes
Services performed by a qualified occupational
therapist, in the home health setting, in the
establishment or delivery of a safe and effective
theragy maintenance progJam, each 15 minutes
Occupational therapy, in the home, per diem
Services performed by a qualified occupational
therapist assistant in the home health or hospice
setting, each 15 minutes
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Once line item rehab utilization had been identified for each individual,
they were combined to estimate rehabilitation services utilization and cost. Total
rehabilitation costs were summarized using means and medians and were later
used to examine their relative proportion to marginal versus total stroke costs.

4.5. Data Set Construction: Aim 2
The data set constructed for aim 2 utilized the 2004 index stroke cohort
from aim 1 as stroke cases without excluding patients who died in the hospital
during index stroke. A large pool of non-stroke Medicare beneficiaries from the
same year was used from which to draw the control population. Propensity score
matching was performed to match two controls to each case. Total medical care
costs were then aggregated for all controls in the same manner as was done for
the stroke cases.

4.6. Statistical Analysis Methods: Aim 1
,

Means and standard deviations were calculated to describe continuous
data for each stroke cohort in aim ·1. Frequencies and percents were calculated
to describe categorical data. To test for differences in stroke rates, demographic
and outcome variables between the two stroke groups, chi-square statistics were
used to test for differences in proportions non-parametric. While Wilcoxon/MannWhitney U statistics were used to test for differences in medians (or ranks).
Graphing was used as needed to test assumptions as well as to display results.
Univariate statistical comparisons between groups provide a good initial
indication of potential significant differences in individual variables. They do not,
however, adjust for potential confounding covariates commonly influential in non-
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randomized studies and thus must be examined further by using multi-variable
analysis methods when group differences are found.
Frequencies and percents were calculated to describe rehabilitation
services utilization in each of the stroke groups ("early" versus "late"). To test for
differences in whether or not the proportion of patients over the outpatient
rehabilitation cap was different between the early and late groups, chi-square
statistics were calculated. When differences between groups were found, logistic
regression was used to control for covariates that differed between the groups
and that were potentially related to the outcome. Covariates included in initial
models were: age, gender, race, Charlson morbidity score, and number of days
alive in the year after index stroke. Covariates not found to significantly contribute
to each model were removed one at a time and the models were then re-fit to the
data. Final models and covariates are discussed in the results chapter.
I

Generalized linear modeling techniques were used to test the hypotheses
that the total and outpatient provider costs of rehabilitation-related care were
different between early and late groups. To correct for the non-normal distribution
of Medicare costs, gamma distributed generalized linear models using a
logarithmic transformation (Montez-Rath, Christiansen et. al., 2006) were
analyzed using the PROC GENMOD module in the SAS statistical software
(version 9.2; SAS Institute, Inc., Cary, NC). The use of a gamma distributed
generalized linear model with a log transformed link function has been shown to
be a good method to estimate healthcare cost distributions that are generally
right-skewed, especially when the log transformed dependent variables do not
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have heavy tails or excessive heteroscedasticity such as was found to be true in
these data (Manning, Basu & Mullahy, 2005).
Multicollinearity between covariates was assessed using Pearson
correlation coefficients. No collinearity was found in these data (all p-values >
0.25). Clinically relevant variables were used to determine which covariates were
initially included in the models to control for population differences. Covariate
adjustment was used to control for differences in cost that may be attributed to
other factors. Covariates that were tested for potential confounding in model
estimates of rehabilitation payments included age, gender, race, Charlson
morbidity score, and number of days alive in the year after index stroke. Final
models and covariates are discussed in the results chapter.
Manual backwards selection regression methods were used to decide
which covariates remained in the final models using smallest Akaike Information
I

Criterion (AIC), Bayesian Information Criterion (BIC) values, and covariate pvalues to judge model fit. Variables with p-values greater than 0.20 were
removed from the models if the AIC and BIC values became smaller than in the
previous model containing the covariate. All analyses were performed using SAS
statistical software (version 9.2; SAS Institute, Inc., Cary, NC), and statistical
significance was determined at the 0.05 level.

4.7. Statistical Analysis Methods: Aim 2
The marginal cost of stroke-related healthcare and stroke-related
rehabilitation care was defined as the cost of caring for patients with stroke after
index stroke hospital admission that is over and above the cost of general
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medical care in the non-stroke control group over the same time period. Total
Medicare payments and total rehabilitation services payments were calculated
using means and unadjusted differences between groups were tested using nonparametric Wilcoxon Scores (same as Mann-Whitney U Scores). The marginal
cost of stroke-related rehabilitation was calculated by subtracting the average
total rehabilitation services payments for the controls, from the average total
rehabilitation services payments for the stroke cases. Generalized linear models
controlling for covariate differences were not used for this analysis because
models would not converge and fit properly due to the large number of patients
with no rehabilitation payments. However, because adjusted estimate results for
total Medicare payments were so similar to their unadjusted results, the inability
to utilize adjusted models in this case is not a major concern.
Generalized linear modeling techniques were used to estimate average
,

annualized total Medicare payments for stroke cases and controls and to test for
differences between the stroke case and control groups. The 1-year marginal
cost of stroke-related healthcare was calculated by subtracting the estimated
total Medicare payments for the controls from the estimated total Medicare
payments for the stroke cases.
To correct for the non-normal distribution of Medicare costs, gamma
distributed generalized linear models using a logarithmic transformation (MontezRath, Christiansen et. a/., 2006) were analyzed using the PROC GENMOD
module in the SAS statistical software (version 9.2; SAS Institute, Inc., Cary,
NC). The use of a gamma distributed generalized linear model with a log
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transformed link function has been shown to be a good method to estimate
healthcare cost distributions that are generally right-skewed, especially when the
log transformed dependent variables do not have heavy tails or excessive
heteroscedasticity such as was found to be true in these data (Manning, Basu &
Mullahy, 2005).
Multicollinearity between covariates was assessed using Pearson
correlation coefficients. No collinearity was found in these data (all p-values >
0.25). Clinically relevant variables were used to determine which covariates were
initially included in the models to control for population differences. Covariate
adjustment was used to control for differences in cost that may be attributed to
other factors. Covariates that were tested for potential confounding in model
estimates of rehabilitation payments included age, gender, race, Charlson
morbidity score, and number of days alive in the year after index stroke. Final
I

models and covariates are discussed in--the results chapter.
Manual backwards selection regression methods were used to decide
which covariates remained in the final models using smallest Akaike Information
Criterion (AI C), Bayesian Information Criterion (BIC) values, and covariate pvalues to judge model fit. Variables with p-values greater than 0.20 were
removed from the models if the AIC and BIC values became smaller than in the
previous model containing the covariate. All analyses were periormed using SAS
statistical software (version 9.2; SAS Institute, Inc., Cary, NC), and statistical
significance was determined at the 0.05 level.
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Propensity score (PS) methods were employed to match cases to
controls. The first step in this process was to perform logistic regression analysis
to estimate the propensity of being "allocated to the stroke group". A propensity
score for each individual was calculated and appended onto the analysis data
set. Known components related to the risks of having a stroke were included as
covariates in the logistic regression model (Brookhart, Schneeweiss et. a/.,
2006). Covariates used in the PS model included age, gender, race, Charlson
comorbidity score, and the following stroke risk factors (as monitored in billing
records from the six months prior to index study start date): diabetes, heart
failure, heart attack, atrial fibrillation, and hypertension as well as five interaction
terms of gender by each risk factor. Final model selection was based on
hypothesis testing of balance between groups of all the covariates included in the
propensity score logistic regression models, model with largest r-square value,
,

and satisfied reduction of the absolute stC\ndardized differences in means
between the matched and unmatched data for all covariates «0.25).
Propensity score methods using a greedy-match algorithm with caliper
distance set to a width of 0.1 standard deviations of the logit of the estimated
propensity score and a 1 case to 2 control matching scheme, without
replacement, was used to match cases with controls in the final analytical data
set. Simulation studies have shown this method to result in superior overall
performance that eliminates systematic differences between treatment groups
(Austin & Mamdani, 2006; Austin, 2009).

5. RESULTS
5.1. Aim 1 Results
5.1.1. Study Cohort Groups Identification and Descriptive
Characteristics
1997 Stroke Group
4,192 patients initially eligible for the "early cohort", who were hospitalized
for all stroke and ischemic events in 1997, were identified for this aim in a 1997
stroke cohort file provided by the SC ORS. Of these patients, 113 (2.7%) had
their index stroke in 1996 and were excluded from this analysis. Of the remaining
4,079 patients, 539 (12.9%) were also excluded as they were under the 65 year
age required for study inclusion; 30 (0.70/0) patients had unknown race; 393
(9.4%) had a primary hospital diagnosis other than the ischemic inclusion codes
434.xx or 436.xx; 172 (4.1 %) patients had claims in the prior 6 months indicating
a prior ischemic stroke diagnosis; and an additional 278 (6.6%) patients had
expired while in hospital for the index stroke and were therefore excluded
because they were never eligible to receive post-acute outpatient rehabilitation
services. This left a patient sample of 2,667 in the final 1997 ischemic stroke
cohort. The process of exclusion is depicted in Figure 5-1.
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2004 Stroke Group

The 2004 "late cohort" consisted of 4,065 SC Medicare patients who were
hospitalized for stroke and ischemic events in 2004 in a 2004 stroke cohort file
provided by the SC ORS. Of these patients, 81 (2.0%) had their index stroke in
2003 and were excluded from this analysis. Of the remaining 3,984 patients, also
excluded were 575 (14.10/0) who were under the 65 year age required for study
inclusion, 22 (0.50/0) patients with unknown race, 231 (5.7%) who had a primary
hospital diagnosis other than ischemic inclusion codes 434.xx or 436.xx, 152
(3.70/0) patients with claims in the prior 6 months indicating prior ischemic stroke
diagnosis, 28 (0.7%) with a previous index stroke in 1997 and who were already
included in the 1997 cohort, and an additional 297 (7.3%) patients who expired
while in the hospital for index stroke and were never eligible to receive post-acute
outpatient rehabilitation services. This left a final patient sample of 2,679 in the
,

final 2004 ischemic stroke cohort. The exclusion categories are provided in
Figure 5-1.
Group Comparisons

The 1997 and 2004 stroke cohorts did not differ significantly with respect
to gender, proportion that died in the year post stroke, the average number of
days alive in the year after stroke, or average Charlson morbidity score (Table 51). However, the 2004 cohort had a statistically significant higher average age
(77.9 versus 76.8 years, p-value<0.0001), by just over a year, than the 1997
cohort (Table 5-1). This statistically significant finding may not be of clinical
significance, but rather be a mathematical phenomenon commonly seen in large
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samples where small differences may be statistically significant, but not clinically
important. The later cohort had a slightly higher proportion of Caucasians than
the earlier group (71.8% versus 68.8%, p-value=0.02). Interestingly, the 2004
stroke cohort had a smaller average index hospital length of stay than the 1997
group, by less than one day (6.8 versus 7.6 days, p-value<0.0001), which may
reflect the general trend toward shorter hospital stays over time for many
illnesses observed nationwide in the past 15 years (Bueno, Ross et. al., 2010;
Clarke & Rosen, 2001; Kominski & Witsberger, 1993).
The 2004 cohort also comprised of a higher proportion of individuals who
received rehabilitation services after the acute index hospitalization and who had
a higher average number of rehabilitation bills in the year following their index
stroke. These rehabilitation related outcomes are not baseline measures rather
they are directly related to the primary outcomes of this study but were included
in Table 5-1 for description only. It is irrfportant to note that use of post-acute
rehabilitation increased from 20.5% in 1997 to 48.6% in 2004 in SC Medicare
beneficiaries who had an ischemic stroke (Table 5-1). This increase in utilization
of rehabilitation services of 28.1 % (p-value <0.0001), is illustrated in Figure 5-2.
Also important to note is the increase in the average number of rehabilitation bills
from 1.4 in 1997 to 4.5 per patient in 2004 (p-value <0.0001) (Table 5-1). Not
only did the rehabilitation bills increase but the standard deviation in the number
of rehabilitation bills increased almost three fold (Table 5-1). This indicates a
larger variation in the amount of care provided and may reflect high utilization of
health care services by a small proportion of individuals.
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Table 5-1. Demographics and Characteristics of Ischemic Stroke Patients
Overall
(n=5,346)

1997 Stroke Group
(n=2,667)

2004 Stroke Group
(n=2,679)

p-value*

Age (approximate)t

77.4 (±6.8)

76.8 (±6.8)

77.9 (±6.9)

Maie A

2102 (39.3)

1070 (40.1)

1032 (38.5)

0.22

CaucasianA

3759 (70.3)

1834 (68.8)

1925 (71.8)

0.02

Died yr post-stroke A

1332 (24.9)

659 (24.7)

673 (25.1)

0.74

Days Alive year post-stroke t

308.0 (±111.0)

308.8 (±109.9)

307.2 (±112.1)

0.62

Charlson Morbidity Score t

3.1 (±1.6)

3.1 (±1.6)

3.1 (±1.6)

0.11

Length of Stay (days) t

7.2 (±6.3)

7.6 (±6.5)

6.8 (±6.0)

<0.0001

Receiving Rehabilitation A

1849 (34.6)

546 (20.5)

1303 (48.6)

<0.0001

# of Rehab. Bills t

3.0 (±10.2)

1.4 (±5.0)

4.5 (±13.3)

<0.0001

<0.0001

t Mean (±SO)
"N (%)
*p-values were calculated using non-parametric Wilcoxon Scores for continuous measures, Chi-square or Fisher's Exact
for categorical measures (as appropriate).

5.1.2. Characteristics of Stroke Patients Receiving Rehabilitation
Services
Of the 2,667 ischemic stroke pati(tnts in the 1997 group, 546 had at least
one post-acute index hospitalization bill with a rehabilitation services procedure
or diagnosis code included. Thirteen hundred and three of the 2,679 patients in
the 2004 cohort had one or more post-acute rehabilitation bills. These subgroups are the main focus of the hypotheses in aim 1, patients using
rehabilitation services in the year after their index stroke (Table 5-2). Within the
cohorts of patients receiving rehabilitation services, there are a number of
demographic variables and study characteristics that are unequal between the
groups. The 2004 group had a higher average age, a lower proportion of males,
and a greater number of days alive in the year after stroke. The groups did not
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differ in race, morbidity, proportion that died in the year after stroke, or in the
length of index hospital stay (Table 5-2).
Table 5-2. Demographic and Characteristics of Ischemic Stroke Patients Using
Rehabilitation Services
Overall
(n=1,849)

1997 Cohort
(n=546)

2004 Cohort
(n=1,303)

p-value*

Age (approximate)t

77.1 (±6.7)

75.8 (±6.6)

77.6 (±6.6)

<0.0001

Male"

806 (39.6)

241 (44.1)

482 (37.0)

0.004

CaucasianJ\

1298 (70.2)

381 (69.8)

917 (70.4)

0.80

Died year post-strokeJ\

347 (18.8)

90 (16.5)

257 (19.7)

0.13

Days Alive yr post-stroke t

328.5 (±87.6)

331.7 (±86.4)

327.2 (±88.1)

Charlson Morbidity Score t

3.1 (±1.6)

3.2 (±1.5)

3.1 (±1.6)

0.06

Length of Stay (days) t

7.2 (±6.0)

7.1 (±5.5)

7.2 (±6.2)

0.51

Over the Cap (all outpatient bills)J\

1016 (55.0)

174 (31.9)

842 (64.6)

<0.0001

52 (9.5)

75 (5.8)

<0.004

Over the Cap (outpatient provider)" 127 (6.9)
t

<0.0001

Mean (SD)

. . N (%)

*p-values were calculated using non-parametric Wilcoxon Scores for continuous measures, Chi-square or Fisher's Exact
for categorical measures (as appropriate).
r

,.

In unadjusted models assessing the proportion of individuals with
rehabilitation charges above the total outpatient rehabilitation cap, 32.7%
(p<0.0001) more individuals were above the cap in 2004 (capped level of $3,180)
than in 1997 (cap level $3,000) (Table 5-2). However, when examining only the
Medicare Part B provider bills the opposite was found to be true. In the 1997
cohort, 9.5% of stroke patients had Part B expenditures above the total cap while
only 5.8% exceeded the cap in 2004 (p-value <0.004) (Table 5-2). This may be
reflecting a shift in how outpatient rehabilitation services were being billed.
These differences are shown in Figure 5-2.
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Fi ure 5-2. Rehabilitation Services Utilization

Rehabilitat ion Services Use
.1997 . 2004
64.6%
48.6%
31.9%

20.5%
9.5%

5.8%

Receiving Rehabilitation

Overthe Cap (Rehab.

Over the Cap (All Rehab.

(Stroke Cohorts)

Outpatient Provider Bills)

Bills)

5.1.3. Rehabilitation Services Utilization
The findings from the univariate analysis for rehabilitation utilization results
did not change when examined using rT!ultivariable logistic regression models
".

when controlling for clinically relevant covariates: age, gender, days alive in the
year post-stroke, and level of stroke. In 2004, South Carolina ischemic stroke
patients over the age of 65 who were-hospitalized for their stroke, and who
received some type of rehabilitation services after their index hospitalization, had
3.7 (p-value <0.00001) times the odds of exceeding the total $3,180 outpatient
rehabilitation services cap than those in the 1997 Medicare cohort (based on the
level set the following year at $3,000). If only the outpatient Medicare Part B
provider bills were used to assess the odds of exceeding the cap, the opposite
result was found. The odds of the 2004 cohort exceeding the cap, using only the
provider bills, are 0.60 (p-value <0.007) the odds of being above the cap in 1997.
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When examining rehabilitation services utilization after ischemic stroke
from the provider cost perspective, average payments were higher or remained
similar between the two cohorts (Table 5-3). In order to account for inflation,
1997 Medicare payments were adjusted to 2004 dollars by using the Consumer
Price Index medical care services estimates provided by the Bureau of Labor
Statistics (Consumer Price Index, 2012).
Total rehabilitation costs per patient were greater in 2004 than in 1997,
even after adjusting the data for inflation. Estimated 1-year adjusted total
rehabilitation payments were $9,606 in 2004 compared with $5,691 (inflation
adjusted) in 1997 (p-value <0.001) (Table 5-3). While utilization of any
rehabilitation services after ischemic Stroke increased by 32.7% from 1997 to
2004, the average cost increased by just under $4,000. Although not statistically
significant, the estimated cost of rehabilitation services for Medicare Part B
provider billing appears to decrease slightly over this time period (p=0.12) (Table
5-3). Among patients receiving rehabilitation services, total 1-year Medicare
payments fell from 1997 to 2004 by $3,987 (p<0.001) (Table 5-3).

Table 5-3. Rehabilitation Services Medicare Payments for Stroke Patients Receiving Rehabilitation t

Total Medicare Payments

Overall

1997 Cohort

1997 Adj. CohortS

2004 Cohort

(n=1849)

(n=546)

(n=546)

(n=1303)

p-value*

33,882 (23921)

29,632 (20362)

39,707 (27285)

35,663 (25028)

<0.0001

39,565

35,578

<0.001

5,060 (10646)

8,530 (10695)

0.02

5,691

9,606

806 (3659)

1,208 (3204)

0.0004

Estimated Total Medicare Payments#

Total Rehab. Payments

7,127 (10193)

3,776 (7945)

Estimated Total Rehab. Payments A

<0.0001

aT

1,029 (3089)

602 (2953)

PT

2,478 (4854)

994

(30~9)

1,332 (4153)

3,100 (5301)

<0.0001

SLP

569 (2366)

264

(~806)

354 (2420)

697 (2555)

0.0002

PT & SLP

3,047 (5985)

1,258 (4377)

1,686 (5865)

3,797 (6397)

<0.0001

General (unspecified)

3,050 (6265)

1,916 (4524)

2,568 (6063)

3,525 (6810)

0.20

847 (4023)

769 (1476)

1,031 (1978)

879 (4696)

1,052

833

Provider Rehab. Payments

Estimated Provider Rehab. Payments$

<0.0001
0.12

t All payments are in US$ and are reported as mean (SO); charges have been rounded to the nearest dollar.
1997 payment amounts adjusted to 2004 US$ using Consumer Price Index series CUUROOOOSAM2 annual medical care services 1.34 adjustment (Bureau of Labor Statistics)
*p-values for univariate comparisons were calculated using non-parametric Wilcoxon Scores for continuous measures,
# p-value for estimated total Medicare payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear Model, controlling for race and number of days
alive in year post stoke.
II p-value for estimated total rehabilitation payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear Model, controlling for race, age
approximation, number of days alive in year post stoke, and stroke severity.
$ p-value for estimated outpatient rehabilitation payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear Model, controlling for gender, race,
and number of days alive in year post stoke.
$
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5.2Aim 2 Results
5.2.1

Characteristics of the 2004 Stroke Cohort and the Matched
Control Group

The 2004 Ischemic stroke cohort used in aim 2 of this study is very similar
but not identical to 2004 group used in aim 1. Figure 5-1 shows the flow diagram
of how the stroke groups were selected. The aim 2 ischemic stroke cases were
selected identically to the approach used in aim1 until the final exclusionary step
where subjects who died in-hospital after their index stroke were either excluded,
as was completed in aim 1, or not excluded, as was completed in the present
aim.

The primary purpose of aim 1 was to evaluate post-acute stroke
rehabilitation, which requires all subjects to be alive after acute treatment in order
,

to have the opportunity to receive

rehabnit~tion

services. In aim 2, the goal is to

estimate the 1-year marginal cost ··of stroke for all ischemic stroke patients over
age 65, including those that die during initial hospitalization. For this reason, the
stroke group in aim 2 of this study differed slightly in sample size and population
composition to that of aim 1. Two thousand nine hundred and seventy six
ischemic stroke cases were matched to a cohort of 5,952 controls on age,
gender, race, Charlson morbidity score, and the following stroke risk factors (as
monitored in billing records from the six months prior to index study start date):
diabetes, heart failure, heart attack, atrial fibrillation, and hypertension using a PS
matching procedure. Potential control patients were excluded if billing data for
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their indexed year, or prior six months, contained ischemic stroke diagnosis
codes. In addition to the nine covariates listed above, five interaction terms of
gender by each risk factor were also included in the propensity model in order to
help achieve an improved gender balance. Controls were selected from a group
of 17,924 potential Medicare beneficiaries that met the same inclusion criteria
used to select the ischemic stroke cohort. A, two controls to one stroke case,
matching scheme was performed based on propensity score similarity via a
computerized matching algorithm as discussed in the methods section.
Table 5-4. Demographics and Characteristics of 2004 Ischemic Stroke Patients
and Matched Controls
Overall
(n=8928)

2004 Stroke
(n=2976)

Age (Approximate) t

78.2 (±6.B)

Maie A

2004 Controls
(n=5952)

p-value*

78.1 (±6.9)

78.3 (±6.8)

0.14

3510 (39.3)

1149 (38.6)

2361 (39.7)

0.33

Caucasian A

6374 (71.4)

2148 (72.2)

4226 (71.0)

0.24

Charlson Morbidity Score t

2.1 (±1.7)

7.1
,.

2.0 (±1.6)

0.10

Receiving Rehabilitation A

2438 (27.3)

1303 (43.8)

1135(19.1)

<0.0001

Died Year Post-Index Date A

1975 (22.1)

967 (32.5)

1008 (16.9)

<0.0001

Days Alive Yr Post-Index Date t

309.1 (±115.2)

279.2 (±136.1)

324.0 (±99.8)

<0.0001

Stroke Risk Factors (prior 6 months)
Diabetes A
3018 (33.8)
Heart Failure A
2606 (29.2)

991 (33.3)

2027 (34.1)

0.48

851 (28.6)

1755 (29.5)

0.38

Heart AttackA

767 (8.6)

280 (9.4)

487 (8.2)

0.06

Atrial Fibril/ationA
Hypertension A

2423 (27.1)

832 (28.0)

1591 (26.7)

0.22

7512 (84.1)

2476 (83.2)

5036 (84.6)

0.09

(±1.7)

t Mean (±SD)
"N (%)
*p-values were calculated using non-parametric Wilcoxon Scores for continuous measures, Chi-square or Fisher's Exact
for categorical measures (as appropriate).
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5.2.2 Propensity Score Matching Results
Each of the propensity score matched covariates resulted in statistically
equal groups on these known potentially biasing factors. Unadjusted outcomes
such as, average number of days alive in the year after index study start date
(stroke date for the stroke cohort and randomly selected 2004 medical bill date
for the control group), proportion receiving any rehabilitation services in the year
after index date, and proportion who died in the year after index study date, were
all higher in the stroke cohort versus the control group (p-values <0.0001) (Table
5-4).
A plot of the absolute standardized differences in means, as seen in
Figure 5-3, offers a good representation of whether selection bias of known
factors has been reduced by matching on propensity score (Stuart, 2010).
Balance (i.e. reduction in standardized mean differences between stroke cases
I

and selected controls) for each covariafe that was used in the logistic regression
model of propensity, is improved when differences are reduced after matching to
no greater than 0.25 (Rubin, 2001). Figure 5-3 illustrates that the standardized
differences in means for each of the fourteen covariates included in the
propensity model is reduced to less than the 0.25 recommended level after
matching. This resulted in a reduction in selection bias on all known covariates
after matching which is the intended goal of propensity score matching
(Rosenbaum & Rubin, 1983). An added benefit of this matching approach was a
reduction in the selection bias of other unmeasured factors that are correlated
with the known covariates used in this matching algorithm. This gives confidence
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that we have a well matched observational study design that is unlikely to have
much selection bias.

Figure 5-3. Standardized Difference of Means of PS Covariates Before and After
Matchin
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5.2.3 Marginal Cost of Stroke in SC
The estimated average healthcare cost in the first year after ischemic
stroke in 2004 was $27,330 (Table 5-6). Average estimated healthcare costs in
the control group was significantly lower at $18,276 (p-value <0.0001) (Table 56). Therefore, the marginal cost of stroke, defined as the cost of healthcare for
an average individual who has had and ischemic stroke, over and above the
normal average cost seen in a similar group who have not suffered a stroke,
was the difference between these group estimates, or $9,054 (Table 5-6).
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Table 5-6. Rehabilitation Services Medicare Costs for 2004 Stroke Cohort and
Matched Controls t
Overall
(n=8928)

Total Medicare Payments

21,220 (28267)

2004 Stroke
(n=2976)

27,329 (23913)

Estimated Total Medicare Payments#

27,330

1-year Marginal Cost of Stroke-Related Healthcare

$9,054

Total Rehabilitation Services Payments

3,735 (8245)

1,968 (5887)

2004 Controls
(n=5952)

18,165 (29745)
18,276

1,084 (3958)

p-value*

<0.0001
<0.0001

<0.0001

1-year Marginal Cost of Stroke-Related Rehabilitation $2,651
t All payments are in 2004 US$ and are reported as mean (SO); payments have been rounded to the nearest dollar.
*p-values for univariate comparisons were calculated using non-parametric Wilcoxon Scores for continuous measures,
p-values for estimated payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear
Model.

#

The average cost of rehabilitation after stroke in 2004 was $3,735,
significantly more than average rehabilitation services cost for the controls (pvalue <0.0001) (Table 5-6). The difference between the rehabilitation costs in
these two groups is the 1-year marginal cost of stroke-related rehabilitation care,
or $2,651 (Table 5-6.). Both the average total healthcare cost differences and
rehabilitation cost differences are illustrated in Figure 5-4.
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Fi ure 5-4. 1-Year Cost of Ischemic Stroke in SC

i-Year Cost of Ischemic Stroke
(2004)
• Total Cost

II Marginal Cost

$27,330

$9,054
$3,735

Overall Heathcare

$2,651

Rehabilitation Care

The proportion of the marginal cost of stroke that is rehabilitation-related
was greater than the proportion of rehabilitation-related care using total cost of
,

rehabilitations services and total cost of fiealthcare (29.30/0 versus13.7 %
respectively, p-value=0.004).

6 DISCUSSION
This research examines rehabilitation services utilization and healthcare
cost during the year after acute ischemic stroke in South Carolina. More
specifically, how the caps on outpatient rehabilitation services required by the US
Balance Budget Act of 1997 impacted utilization and cost by comparing stroke
cohorts from before and after the legislation was enacted. The one-year
attributable healthcare costs of ischemic stroke was also examined by calculating
the marginal estimated healthcare Medicare payment difference between a 2004
ischemic stroke cohort and a propensity matched 2004 non-stroke control group.
This latter question is innovative

becau~e

the marginal cost of illness has never

been published for an elderly stroke cohort, and marginal cost is the preferred
method of cost of illness estimation for many purposes; specifically, it is an
essential input for cost-effectiveness studies for this disease group.
One of the objectives of this research was to estimate the proportion of
healthcare dollars spend on rehabilitation services in the year after ischemic
stroke. Estimates of rehabilitation expenditures are extremely varied and are
often underestimated due to the fact that they are estimated as a proportion of
annual total healthcare expenditure, rather than as a proportion of the marginal
cost attributable to a specific illness. Because the type of data available to
answer these questions is retrospective observational billing data, special
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methods must be used to properly minimize selection bias. Also, because costs
are being estimated, statistical methods should be used that can effectively
model skewed distributions that are commonly associated with healthcare costs.
There are four primary findings from this research. First, the BBA of 1997
outpatient rehabilitation services caps did constrain the costs of Medicare Part B
provider services when rehabilitation bills were examined. However, the second
finding was that all other rehabilitation services billing contained within outpatient
facility charges continued to rise significantly over the study time period. Third,
findings related to the second study aim clearly demonstrated that the total cost
of healthcare after ischemic stroke significantly overestimates the cost of stroke
as an illness because the marginal cost of stroke in this elderly population is
attenuated by healthcare costs related to comorbidities. Fourth, estimates of the
proportion of healthcare dollars spent on rehabilitation services using total annual
,

healthcare expenditures, rather than margi.nal costs, underestimates the
proportion of rehabilitation services used after stroke. The proportion of dollars
spent on stroke-related rehabilitation services is better estimated by calculating
marginal stroke-related healthcare costs rather than total healthcare costs. This
is because the amount of expenditures incurred for other non-stroke related
healthcare needs in this older population is quite large. These findings and
related issues are discussed below, followed by a discussion of the limitations of
this study, future directions, and opportunities in this line of research.
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6.1 Aim 1 Discussion
The first aim of this study examined the cost and utilization of rehabilitation
services before and after the 1997 BBA. The proportion of stroke patients
exceeding the cap in 2004 after the 1997 BBA was enacted, was lower (5.8 %)
than those in 1997 (9.5%) had there been a cap at that time (p-value=0.004).
These numbers, however, do not reflect the

t~ spending on rehabilitation

services outside of hospital settings. They represent only the portion of
rehabilitation services that are billed to Medicare via Part B outpatient provider
files.
Rehabilitation services can also be billed via home health facility,
outpatient facility, and skilled nursing facility billing. When we examined the
proportion of individuals exceeding the cap among both the outpatient provider
and facility files, there was a greater proportion of stroke patients in 2004 (64.60/0)
,

than in 1997 (31.90/0) who exceeded the" cap (p-value <0.0001). The same
relationship was found when examining the 1-year cost of rehabilitation services
after acute ischemic stroke among patients who are eligible for these services.
The estimated average 1-year Medicare payments for rehabilitation services,
when examining only the Part B outpatient provider bills, did not differ between
the cohorts (p=0.12), and, in fact, decreased slightly from $1 ,052 in 1997 (after
adjustment for inflation) to $833 in 2004. However, when examining rehabilitation
costs using all available outpatient Medicare bills, the average estimated
payments greatly increased (p-value <0.0001) from 1997 when it was $5,691 to
$9,606 in 2004 after inflation adjustment.
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These results suggest that billing practices may have changed in
response to the outpatient rehabilitation services caps enacted by the BBA of
1997. Rehabilitation services billing may have shifted from Part B provider bills to
being more frequently included in facility charges. In fact, the average number of
bills containing an indication of services performed by aPT, OT, or SLP
increased greatly over this time period from 1.4 in 1997 to 4.5 per patient in 2004
(p-value <0.0001 ).
Not only did the number of rehabilitation bills increase but we observed a
greater variation in billing as indicated by the standard deviation in the number of
rehabilitation bills increasing almost three fold. This indicates a larger variation in
the amount of care provided and may reflect a high utilization of health care
services by a small proportion of individuals which has been noted in numerous
reports (Andersen & Newman, 2005; McKinsey and Company, December 2008)
to be a major contributing factor of the exp.onential growth of US healthcare
expenditures. It should also be considered a warning that potential disparities in
access to care could be increasing.
In addition, the number of stroke patients receiving some amount of
rehabilitation services after acute ischemic stroke has greatly increased during
this time period. The proportion of patients using rehabilitation services after
their stroke increased from 20.5% in 1997 to 48.6% in 2004. This increase in
utilization of rehabilitation services of 28.1 % (p-value <0.0001), reflects an
important indication that practice is moving toward compliance with
recommendations that all stroke survivors receive at least one evaluation visit
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with aPT, OT, and SLP clinician, and that the unit cost or appropriate utilization
of rehabilitation services may not be the best legislative focus for cost
containment.
No matter what special rules are enacted, healthcare administrators will
find ways to legally bill Medicare for needed provider services. The focus of
healthcare cost containment may be better served by reducing the large amount
of services used by a small portion of the population. The increase in variation of
the amount of units of rehabilitation services used in the year following ischemic
stroke indicate that just over 20/0 of Medicare beneficiaries consume more than
30 rehabilitation services billing units in the year after their 2004 stroke, while this
proportion of high-use behavior in 1997 resulted in the top 2% consuming only 10
or more rehabilitation units. The cap on outpatient rehabilitation per person
annual spending enacted under the BBA of 1997 has also contributed untold time
and related expenditure on legislative, privpte sector, and public research efforts
to lobby, debate, and study the issue with little or no supporting evidence that the
cap is fair or satisfies the goal of cost containment.
From 1998 through 2000, Olshin, Ciolek, and Hwang report that Medicare
Part B expenditures for therapy services dropped by 10.3 % (Olshin, Ciolek &
Hwang, 2002). The findings in this study are not directly comparable to what we
found as a decrease of 14.7% in Part B expenditures from 1997 (adjusted) to
2004. However, because our time frame was longer than the Olshin, Ciolek and
Hwang report it is reasonable that the decrease found in our study is greater but
still in the same direction as this government sponsored research (Olshin, Ciolek
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& Hwang, 2002). When we adjusted our estimates for gender, race, and the

number of days alive that year, the difference was no longer statistically
significant. The Olshin, Ciolek and Hwang group report on all Medicare
beneficiaries while ours include only those diagnosed with ischemic stroke. Some
limitations of the Olshin et. al. report is that the authors do not test for a
statistically significant difference and do not address rehabilitation services that
are billed under other facility based bills, such as home health or nursing home.
Another reason for the difference in findings between the current research and
the Olshin report may be because the government report is based on a national
sample.
Indeed, according to US congressional committee members' response to
the analysis performed by Olshin, Ciolek and Hwang, the Computer Sciences
Corporation (CSC) results were considered insufficient for informing health
,

policy, written in a report from the US government accountability office (GAO) in
2005 (Grassley, Baucus et. al., 2005). In the GAO report, "Little progress made in
"

targeting outpatient payments to beneficiaries needs", the congressional GAO
authors stated that "the [CSC] contracted analysis of claims data does not show
any particular conditions or diseases as more likely than others to be associated
with payments exceeding the therapy caps" (Grassley, Baucus et. al., 2005).
They go on to suggest that even for conditions such as stroke, claims data
analysis shows that the length of treatment varies widely (Grassley, Baucus et.
al., 2005). This is one of the reasons why the current in-depth study, focused
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specifically on stroke patients, may contribute substantially to informing health
policy.
In the most recent analysis by Ciolek and Hwang, the authors remark that
the initial problems with reduced access to outpatient rehabilitation services seen
in the early years of the caps appears to no longer be notable once the
exceptions process was put in place (Ciolek & Hwang, 2008). Our conclusions
are similar to this report in that it appears that once the healthcare system had
time to adjust to the legislation it was able to provide services in different
locations. Thus, access issues do not appear to be a problem in the current
study, consistent with Ciolek and Hwang. Use of rehabilitation services by larger
proportions of the Medicare population continue to increase.
In a study published by the CDC based on 2005 BRFSS survey data,
30.7% of stroke survivors received outpatient rehabilitation (CDC, 2007). This
estimate is much lower than found in the c~rrent study, where 48.6% of SC
Medicare patients who survive hospitalization after ischemic stroke receive
rehabilitation services. In additional to other limitations of BRFSS data related to
survey sampling, the lower estimate in the BRFSS survey may be due to the fact
that those data are based on subjective recall and only represent noninstitutionalized individuals which excludes anyone in nursing home or inpatient
rehabilitation facilities at the time of the survey. Also, rehabilitation rates may
vary from the national sample to the current South Carolina based study data.
Nevertheless, these estimates continue to indicate that there may still be a
concern that clinical practice guidelines recommend outpatient rehabilitation for
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the majority of stroke survivors (Adams, Brott et. a/., 1994; Adams, del Zappa et.
a/., 2007). It is quite unlikely that the more than half of stroke patients who do not
receive rehabilitation services do not need, at a minimum, rehabilitation
assessment. We suspect that these patients simply are unable to negotiate the
entry points into the rehabilitation system. This may be a serious problem for
patients with low health literacy, without family support in negotiations, and with
cognitive impairments that make them poor advocates for themselves.
6.2Aim 2 Discussion
The second aim of this study examined the 1-year difference in healthcare
costs between a group of SC Medicare beneficiaries who had suffered an
ischemic stroke in 2004 and a propensity score matched control group of 2004
non-stroke SC Medicare beneficiaries. In 2004, the estimated marginal cost of
stroke-related healthcare in the year after ischemic stroke in SC was $9,054.
,

This amount reflects the difference

betwe~n

the annualized healthcare cost of

the stroke group of $27,330 less the healthcare costs of the propensity score
matched non-stroke control group of $18,276 (p-value <0.0001). Similarly, the
2004 marginal cost of stroke-related rehabilitation services in the year after
ischemic stroke was $2,651, resulting from a statistically significant difference
between the average annualized total rehabilitation services cost for the stroke
group of $3,735 and the control group of $1 ,064 (p-value <0.0001). Both the
average total healthcare cost differences and rehabilitation cost differences are
illustrated in Figure 5-4.
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While these amounts are substantial and both clinically and statistically
significant, they are lower than is commonly quoted as the annual cost of care
after stroke. A 1996 publication by Taylor, Davis and colleagues is the most
commonly cited cost of stroke paper with 559 publications referencing this
research (accessed May 2012) . The Taylor study continues to be referenced
annually in the stroke cost section by the most well-known review publication on
stroke statistics, "Heart Disease and Stroke Statistics-2011 update: A report
from the American Heart Association" (Lloyd-Jones, Adams et. al., 2009; LloydJones, Adams et. al., 2010; Roger, Go et. al., 2011b; Rosamond, Flegal et. al.,
2007; Rosamond, Flegal et. al., 2008), even though this research is based on
1990 data and uses antiquated methodology. This is likely true because there
have been no more recent, population-based studies on the cost of stroke.
The authors of the Taylor study estimated the 1990 annual direct cost of
,

ischemic stroke in the 65-74 year age groLJP to be $17,823 ($35,197 in 2004
dollars) versus the annual healthcare expenditures for their control group of
$2,825 ($5,579 in 2004 dollars) (Taylor, Davis et. al., 1996). This study reports
the annual direct marginal cost of ischemic stroke of $14,998 in 1990 dollars
($29,618 in 2004 inflated dollars) which is much higher than we found in the
current research. Differences between the current research and that undertaken
by Taylor and colleagues in their 1997 publication are related to differences in
the methods used to estimate these dollar amounts and in changes in healthcare
practice patterns.
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A significant trend toward shorter hospital average length of stay has
been frequently reported in the literature. In this case, the Taylor study reports
that 70% of the first year of medical costs can be account for by the initial
hospitalization; however, the article does not report the average length of stay. In
the current study, initial hospital costs only account for 35% of the first year of
total healthcare costs. This reflects a change in practice patterns of shorter
average hospital stays from the 1980s to today (Bueno, Ross et. a/., 2010;
Clarke & Rosen, 2001; Kominski & Witsberger, 1993). Shorter length of stay
would result in lower first year healthcare cost estimates in later studies, however
these reductions may be counteracted by inflation adjustment over time.
The Taylor et. al. study includes a 5% Medicare sample of the 1990 US
population, while the current study uses all SC Medicare patients with ischemic
strokes in 2004. Taylor et. al. also used an average cost to charge ratio for all
admissions to estimate stroke costs whil~ the current research used actual
Medicare payments. Estimates based on cost to charge ratios for all admissions
can skew costs because stroke costs may not follow general hospital cost to
charge trends. While the current research uses actual payments made by
Medicare to the provider and does not make any assumptions in the costing
methods. Also, the Taylor research used a 1 in 1,000 randomly selected, nonmatched control group from the general US Medicare population. This practice
would likely under estimate the control groups' healthcare expenditures because
the average Medicare population is more likely to be healthier than a control
group matched on an equally at-risk population. This, outdated matching
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approach, would result in inflated marginal cost estimates. This study addresses
the potential selection bias caused by unmatched controls by using propensity
score matching to match the stroke cases to controls, which results in a more
conservative and reasonable marginal cost estimate. An added benefit of the
matching approach used in the current study was a reduction in the selection
bias of other unmeasured factors that are correlated with the known covariates
used in this matching algorithm. This gives confidence that the observational
study is well matched and is unlikely to contain much selection bias.
In a seminal study by Samsa and colleagues, the 2-year cost and survival
after cerebral infarction was estimated based on 1991 data (Samsa, Bian et. a/.,
1999). This publication, which has been cited 130 times (accessed May 2012),
reports the first year cost of first ever ischemic stroke in the over 65 Medicare
population as $29,444 (in 1991 dollars) (Samsa, Bian et. a/., 1999). The Samsa
estimate is very similar to the current stady's 1-year cost estimate of $27,330, but
the current study is based on 2004 Medicare payments while theirs is calculated
using 1991 data. The Samsa study estimated total average cost rather than
marginal cost. In 1991 the average length of hospital stay after acute stroke was
considerably longer than it was in 2004, resulting in inflated estimates when
compared to current practice. Their estimates also used cost-to-charge ratio
adjusted Medicare charges for all facility bills, rather than payments, which has
an unknown effect on the costs incurred by Medicare. So while this is a good
study on the cost of ischemic stroke using a comparable population the estimates
provided by Samsa et. al. are no longer applicable to the current healthcare
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system and do not take into account the cost of the non-stroke care that surviving
stroke patients are likely to incur even if they did not have a stroke.
The Samsa study exemplifies the inflated estimation of costs that result
from reporting total healthcare cost instead of marginal cost of care, particularly
in the group examined in this study. Older individuals tend to have significant
healthcare costs outside of the particular major illness being studied, which make
it essential to take into account other costs when estimating the costs attributable
to a single disease.
In a more recent study by Brown et. aI., epidemiological modeling was
performed to estimate the cost burden of ischemic stroke from 2005 through
2050 (Brown, Boden-Albala et. al., 2006). The authors suggest that they use
marginal cost in their projections for hospital and nursing home expenditures;
however, they reference the Samsa paper for these amounts which are not
based on marginal cost. Also, the reseafct"1 published by Brown and colleagues is
not population based, but is mode"led by using previously published results from
studies covering many different time periods, using different methodology.
Furthermore, it is not clear if and how the authors adjust for inflationary trends
which add to questions raised on the quality of their research estimates.
The use of total annualized healthcare expenditures to estimate the cost
of a certain illness may also contribute to underestimation of certain portions of
the cost attributable to specific healthcare services. For instance, within the 2004
stroke cohort, the proportion of total healthcare costs spent on rehabilitation
services is 13.7 %

,

as illustrated in Figure 6-1. However, if one uses the 2004
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marginal costs of stroke and rehabilitation services due to stroke, the proportion
of costs attributable to rehabilitation services is 29.3%. Since our goal is to
specify costs of care that are specifically due to ischemic stroke, the marginal
cost is the better method of estimation of these costs because they exclude the
expected cost of non-stroke related healthcare that patients would have used if
they did not have a stroke. Thus, as illustrated in Figure 6-1, the estimation of the
proportion of dollars spent on rehabilitation care after stroke is undervalued by
two-fold unless marginal cost estimation is used. This error can be found in the
commonly referenced estimates by Taylor and colleagues, based on 1991 data,
which state that 70% of first-year post-stroke costs are accounted for by inpatient
hospital costs (Taylor, Davis et. a/., 1996). Not only is this proportional estimate
based on total annualized healthcare costs, but it is also from a time period
where hospital length of stay was considerably longer and therefore more
expensive than what is true in healthcar~ t~day.
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Figure 6-1. Proportion of the 1-Year Cost of Ischemic Stroke Spent on
Rehabilitation Services

i-Year Cost of Ischemic Stroke
(2004)
• Total Cost

II Marginal Cost

29.3%

13.7%

Proportion Spent on Rehabilitation

Ciolek and Hwang reported in 2006 that outpatient therapy services
payments for rehabilitation totaled $4.07 billion in 2006 (Ciolek & Hwang, 2008).
Of these PT accounted for 75%, OT for,,. 18.4% and SLP 6.6% (Ciolek & Hwang,
2008). They observed that the relative proportion of services by therapy type was
consistent with prior years. These estimates were based on data from 4,419,907
individuals for a mean expenditure per person $921 (Ciolek & Hwang, 2008)
which corresponds closely to the findings for the per person annual expenditure
of our 2004 control group of $1,084. The slightly higher number found in the 2004
control group could be due to the exclusion of individuals under 65 years of age
which were not excluded in the Ciolek and Hwang report. The Ciolek and Hwang
reported 2004 expenditures, provided in Figure 2 page 8 of the 2006 report
indicates a mean expenditure of $1 ,000 per individual (Ciolek & Hwang, 2008).
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The close correlation of the findings between Ciolek and Hwang and the current
study indicate that the findings in this study have high external validity.
Based on stroke estimates from the current study, 1-year total healthcare
cost to SC Medicare in 2004 of beneficiaries having ischemic stroke was
$81,334,080 and total annualized 2004 SC Medicare rehabilitation costs due to
ischemic stroke was $11,115,360 (Table 6-1). However, if quoting marginal
rather than total cost, the annualized stroke-related healthcare costs to SC
Medicare in 2004 were $26,944,704 (Table 6-1). This reflects a potential $54.4
million over-estimation of Medicare expenditures that were not due to ischemic
stroke. Similarly, the marginal cost of stroke-related rehabilitation care in 2004 in
SC Medicare patients having ischemic stroke was $7,889,376, resulting in a $3.2
million over-estimation if total rehabilitation costs are quoted (Table 6-1).
Table 6-1. Cost of Ischemic Stroke to Medicare in SC and the US

Total Cost

2004 SC
Stroke
Costs

2012
Projected
SC Stroke
Costs

2012
Projected
US Stroke
Costs

2004 SC
RehabRelated
Stroke
Costs

2012
Projected
SC
RehabRelated
Stroke
Costs

2012
Projected
US
RehabRelated
Stroke
Costs

$81.3 M

$109.5 M

$7,319.3 M

$11.1 M

$15.0 M

$1,000.3

M
Marginal Cost

$26.9 M

$36.3 M

$2,424.8 M

$7.9 M

$10.6 M

$710.0
M

Differential

$54.4 M

$73.2 M

$4,894.5 M

$3.2 M

$4.4 M

$290.0

M
* Cost estimates are based on costs and incidence rates using the 2004 Stroke Group from this study and are rounded to
the nearest tenth of a million SUS dollar
# The number of 2004 Medicare beneficiaries used to estimate SC costs to Medicare was taken from Kaiser Family
Foundation State Health Facts website (www.statehealthfacts.org, accessed on 05/25/2012)
t 2012 SUS dollars cost projections were calculated using 2004 estimates inflated by Consumer Price Index series
CUUROOOOSAM2 annual medical care services adjustment (Bureau of Labor Statistics)
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When these 2004 SC Medicare stroke cost estimates are inflated using
the Consumer Price Index for healthcare services to make 2012 dollar
projections, 2012 SC Medicare annualized stroke-related healthcare and
rehabilitation care costs would be over-estimated by $73.2 million and $4.34
million, respectively (Consumer Price Index, 2012) (Table 6-1). When SC stroke
rates and costs estimated in this study are used to predict Medicare costs for all
US ischemic stroke patients, 2012 total stroke costs are predicted to be $7.32
billion compared with 2012 marginal stroke-related healthcare costs of only $2.42
billion, resulting in an over-estimation of stroke-related expenditures of $4.89
billion (Table 6-1). Similarly, utilizing total cost instead of marginal cost figures to
predict stroke-related rehabilitation care costs of 2012 Medicare beneficiaries
would result in an over-estimate of $290 million (Table 6-1 ) ..
There are many policy issues related to the use of inflated estimates for
,

stroke. When it is generally felt that commonly quoted figures related to incidence
rates, prevalence rate"s, proportional estimates of certain services and cost
estimates are inflated, the public, including those in the research community,
begin to become immune to the numbers. The research community may believe
that it is okay to inflate cost estimates in order to help support arguments for
increased funding. However this practice may negatively affect funding for other
important research since there are limited dollars to support health-related
research efforts. Furthermore, when advocacy and governmental groups quote
these inflated estimates they lose credibility with the public and their ability to
make good policy decisions are diminished.

107
For this reason it should be imperative for the research community to
report reasonable findings so that funding agencies can properly designate
research dollars in a balanced manner, commensurate with the degree to which
the healthcare issue affects society. A good example of this is the lower funding
for post-acute stroke rehabilitation research compared with acute stroke
treatment due to the antiquated belief that hospital costs account for the largest
percentage of stroke-related costs.
6.3 Limitations

There are several limitations in the analysis of SC Medicare claims data.
There is an inherent limitation of using administrative claims to ascertain
diagnoses and identify resource use and costs with complete accuracy, because
these data are not purposely collected for clinical research but are collected for
the distinct purpose of making healthcare payments. It is possible that signs or
symptoms related to stroke may not have Qeen captured in the claims, and that
ischemic stroke patients not diagnosed with 434.xx and 436.xx ICD-9-CM codes
under the primary diagnosis category would be missed by this analysis. Similarly,
the measurement of rehabilitation and general resource use in these data
depends on the design and implementation of the Medicare fee-far-service plan
and its scope of coverage which may change over time. Medicare reimbursement
rules and healthcare practice patterns that change over time may also make
these 2004 based results less generalizable to current times. The use of SC
estimates from this research may not be representative of stroke costs and
rehabilitation utilization in other states and in the US since healthcare practice
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patterns and costs vary geographically. In addition, the interpretation of
rehabilitation resource use and the assignment of associated costs are
challenging.
Due to the lack of availability of clinical information in these claims data,
the classification of rehabilitation was based on the inclusion of specific
rehabilitation related codes in the ten diagnosis code and four procedure coding
columns provided in the data files. Provider billing systems will often allow for a
much longer list of these codes when interpreting medical records into billing
data in the clinical setting. So it is reasonable to assume that some diagnoses or
procedures related to stroke and rehabilitation would not be included in the
Medicare data.
Clinical outcomes are not available in billing data and costs can be
significantly influenced by clinical factors such as stroke severity. In response to
this concern, we developed and used a~ qn-validated coding-related stroke
severity measure designed to mimic the NIH stroke scale in our multivariable
analyses. Also, as becomes clear in aim 2 of this study, when using billing codes
to identify rehabilitation resource use, the reason for such use is directly related
to the index stroke. Stroke patients may also receive rehabilitation for other
comorbidities which would then be erroneously counted as stroke-related unless
being accounted for in a marginal use or cost analysis that uses a similarly
distributed control group.
An additional challenge was presented by the way Medicare bills are
aggregated in the data. Facility based bills, such as those listed in outpatient,
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home health, and skilled nursing files, do not provide line-item specific
information. For example, a single bill from a skilled nursing facility can include
one payment for all charges incurred over a

3~-day

period since Medicare's

prospective payment system generally only reimburses these as a single
allowable amount. So while this bill may have procedure and diagnosis codes
that include rehabilitation services, the actual cost of that service is not
differentiated within the payment amount. This differs with Part B provider bills
which are coded on a line-item basis, so each bill will directly reflect the payment
for the service that is specified in the procedure or diagnosis codes.
In addition, we intended to examine differences in payments for provider types
(PT, OT, SLP) but had to abandon this analysis because ICD-9, CPT, and
HCSPCS coding use in the data was too inconsistent to differentiate clearly
between provider types (Appendix B). For example, the most commonly used
CPT/HCSPCS code in the data, "9711 d - Therapy Procedure", is used by both
PT and OT professionals. The co"ding differentiation between provider types
improved slightly between 1997 and 2004 but remained too general to allow for
clear delineation between providers. In theory, modifier codes that designated
the outpatient rehabilitation services practitioner, ("GO" for OT, "GP" for PT, and
"GN" for SLP) were added by Medicare after the BBA 1997 and are required to
be used for all outpatient rehabilitation services billing. However, fewer than 100/0
of bills containing rehabilitation codes actually included modifier designations in
the better coded 2004 Stroke cohort (Appendix B). Thus, the use of these
modifier codes is not well enough implemented to support the identification of the
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type of professional rehabilitation service provider. For that reason we primarily
examined payments for rehabilitation using total rehabilitation services costs
rather than provider specific costs.
Because the goal of the research conducted in aim 1 was to characterize
the utilization and cost of rehabilitation in patients who might be affected by the
caps implemented by the BBA of 1997, rehabilitation cost estimates are for
ischemic stroke patients who survive their acute stroke hospitalization and who
are identified as receiving any rehabilitation services outside of their initial
hospitalization. For this reason, patients who died during the acute hospitalization
or those not identified as receiving rehabilitation services in the year after stroke,
were excluded. Had these patients been included in the cost analyses, the
estimated Medicare costs may have differed.
Lastly, this study evaluated the burden of caring for stroke patients from the
perspective of the Medicare system. Ad~iti,onal costs such as premiums,
deductibles, co-insurance, self-paid items, prescription drugs, and indirect strokerelated expenses were not included in the cost estimates.
6.4 Future Directions and Opportunities

The first research aim of this study compares rehabilitation utilization and
cost before and after the BBA of 1997 enacted caps on outpatient rehabilitation
services. It provided strong evidence that the caps impacted the cost of
rehabilitation services that are billed via Medicare Part B provider services, but
that rehabilitation costs continue to rise when billed in facility settings.
Furthermore, the current research shows that while the use of rehabilitation
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services after hospitalization for ischemic stroke continue to increase, contrary to
current practice guidelines, greater than 50% of eligible Medicare patients do not
receive rehabilitation services after their stroke. It will be important to examine
the population who do not receive rehabilitation services for disparities in access
to care. It will also be important for future research to examine what types of
stroke impairment are most likely to result in clinician referral for post-stroke
rehabilitation care.
The second aim of this study estimated the marginal cost of ischemic
stroke in SC in the 2004 Medicare population over age 65. While healthcare
costs for stroke patients were found to be significantly greater than in the
matched controls, the marginal cost difference between the two was just under
$10,000. This amount may be surprising in its relative smallness when compared
to common estimates quoted in past research, but is largely due to the fact that
the estimate is based on marginal cost aifference and not on total healthcare
dollars spent. Furthermore, the current studies stroke-related healthcare cost
estimate is based on a comparison with the annual healthcare costs of an equally
at-risk matched control group.
In order to generalize these findings, a similar study based on a national
sample should be performed and also be undertaken using more recent data. An
additional analysis should also be performed to update national and global
lifetime cost of stroke estimates that would be valid to replace the 25 year old
data estimates published by Taylor and colleagues (Taylor, Davis et. al., 1996).
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Another future direction for this research is to be able to link healthcare
costs for stroke and rehabilitation with clinical outcomes using different postacute treatment paradigms. Lastly, estimates of the marginal cost of other
illnesses should be performed. Marginal cost of illness methodology is
particularly important to use for chronic diseases. For example, in the case of
diabetes, a chronic disease associated with a great deal of comorbidities over a
long period of time, it is important to generate diabetes-related cost estimates
compared with a well-matched control group to produce practical estimates of
healthcare costs that are due to diabetes rather than other illness.

7 CONCLUSIONS
In the first part of this study, we used Medicare claims from patients with
ischemic stroke in South Carolina in 1997 and 2004 to examine two important
health policy issues related to cost control and cost estimation. We explore the
differences in the proportion of outpatient rehabilitation services cost that fall over
the cap enacted in the Balance Budget Act of 1997. We then examined if the cap
resulted in a reduction in expenditures for stroke prior to and after outpatient
rehabilitation caps were enacted. Next we looked at the effect of using a total
cost approach versus a marginal cost method to estimate the first year cost of
stroke and stroke rehabilitation.
We found that the utilization of rehabilitation services after ischemic stroke
rose sharply between 1997 and 2004. We also found that the BBA 1997 caps did
constrain the proportion of individuals over the outpatient rehabilitation caps in
1997 versus 2004 and that costs of rehabilitation services were similarly
constrained but only if these outcomes were examined using Medicare Part B
provider bills, not when facility costs were also included.
Lastly, we found that using a marginal costing approach to estimate
healthcare costs due to ischemic stroke was important in the Medicare
population compared to using total average costing techniques, in order to
accurately attribute healthcare costs to stroke. Indeed, the average total costing
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approach may be expected to inflate the estimated 2004 SC total cost due to
stroke for Medicare patients by $3.6 billion, because this approach ascribes
expenditures for comorbid conditions to stroke.
Healthcare policy makers should consider other approaches than capping
for controlling costs, and be wary of burden of illness estimates that employ
average total costs for patients who may be expected to have substantial
comorbid disease.

;.
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APPENDICES
A.QQen d'IX A Medicare Data Dictionary of Variables
Variable List
# Variable
16 ADMD

Label
Date of Admission

146 Adj_Sum_rehab_
GEN_pmt

Total Rehab Payments adjusted to 2004
dollars, General

142 Adj_Sum_ rehab_
OT_pmt

Total Rehab Payments adjusted to 2004
dollars, aT

140 Adj_Sum_rehab_P Total Rehab Payments adjusted to 2004
dollars, PT
T_pmt
144 Adj_Sum_rehab_S Total Rehab Payments adjusted to 2004
dollars, SLP
LP_pmt
110 Adj_Total_Charge Total Charges adjusted to 2004 dollars, Total
s
111 Adj_Total_Paymen Total Payments adjusted to 2004 dollars
ts
150 Adj_Total_Rehab_ Total Rehab Payments adjusted to 2004
dollars, Carrier
Carrier_pmt
148 Adj_Total_Rehab_ Total Rehaq. Payments adjusted to 2004
dollars
pmt
122 Adj_rehab_pmt_a
mt_genCA

Total Rehab Payments adjusted to 2004
dollars, General Carrier

121 Adj_rehab_pmt_a
mt otCA

Total Rehab Payments adjusted to 2004
dollars, aT Carrier

120 Adj_rehab_pmt_a
mt_ptCA

Total Rehab Payments adjusted to 2004
dollars, PT Carrier

119 Adj_rehab_pmt_a
mt_slpCA

Total Rehab Payments adjusted to 2004
dollars, SLP Carrier

31 Aphasia

Dichotomous variable 1=has Aphasia code in
SDx, O=no Aphasia code in SDx

152 Carrier_aver_Cap Dichotomous indicator total rehab carrier
charges over the cap, 1=yes, O=no
128 CharAFib
125 CharCHF

Dichotomous variable 1=has Afib code, 0
otherwise
Dichotomous variable 1=has CHF code, 0
otherwise
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Variable List

# Variable
126 CharDiab
127 CharMI
129 Charhichol
130 Charhypertens
133 CharlsScore
134 Cohort
17 DISD
114 DME zero

Label
Dichotomous variable 1=has Diab code, 0
otherwise
Dichotomous variable 1=has MI code , 0
otherwise
Dichotomous variable 1=has Hi Chol code
Dichotomous variable 1=has Hypertension
code, 0 otherwise
Charlson Comorbidity Score
Dichotomous variable 1=1997 group, 2=2004
Group
Date of Discharge
Indicator of Durable Medical Equipment
payment of zero

12 DaysAI ive_yea rpo
ststroke

Continuous number of days alive in the year
after stroke

15 DeathDate

Date of Death using middle of the month (15 th )
imputation

13 Died_yearpoststro Dichotomous variable 1=died in year post, 0=
ke
did not die in year post stroke
32 Dysarthria

Dichotomous variable 1=has Dysarthria SDx
code, O=no Dysarthria SDx code

33 Dysphagia

Dichotomous variable 1=has Dyphagia SDx
code, O=no Dysphagia SDx code

115 HH zero

Indicator of Home Health payment of zero

34 Hemianopia

Dichotomous variable 1=has Hemianopia SDx
code, O=no Hemianopia SDx code

38 Hemiplegia

Dichotomous variable 1=has Hemiplegia SDx
code, O=no Hemiplegia SDx code

116 Hosp_zero

Indicator of Hospital payment of zero

20 Last- follow- date

Last date in study (either end of follow-up year
or date of death)

37 MemLoss

Dichotomous variable 1=has Memory Loss
code, O=no Memory Loss code

118 NH zero

Indicator of Nursing Home payment of zero

134

Variable List

# Variable
36 Neglect
117 OP zero
21 PDx
132 Prior time- max

Label
Dichotomous variable 1=has Neglect SDx
code, O=no Neglect SDx code
Indicator of Outpatient payment of zero
Primary Diagnosis Code
(ICD-9_CM)
Number of maximum prior days available in 6
months before index date

22 SDIAG1

Secondary Diagnosis Code 1 (ICD-9_CM)

23 SDIAG2

Secondary Diagnosis Code 2 (ICD-9_CM)

24 SDIAG3

Secondary Diagnosis Code 3 (ICD-9_CM)

25 SDIAG4

Secondary Diagnosis Code 4 (ICD-9_CM)

26 SDIAG5

Secondary Diagnosis Code 5 (ICD-9_CM)

27 SDIAG6

Secondary Diagnosis Code 6 (ICD-9_CM)

28 SDIAG7

Secondary Diagnosis Code 7 (ICD-9_CM)

29 SDIAG8

Secondary Diagnosis Code 8 (ICD-9_CM)

30 SDIAG9

Secondary Diagnosis Code 9 (ICD-9_CM)

35 Senslmp

Dichotomou~

2 Stroke
39 Stroke_Severity

variable 1=has Sensory
Impairment code, O=no Sensory Impaiment
code
Aim 2 group indicator variable, 1=stroke case,
O=control
Categorical Stroke Severity Score

145 Sum- rehab- GEN- Total payments rehab, General
pmt
141 Sum_rehab_OT_p Total payments rehab, OT
mt
139 Sum_rehab_PT_p Total payments rehab, PT
mt
143 Sum- rehab- SLPpmt

Total payments rehab, SLP

108 Total_Charges

Total charges over study time period

151 Total_Over_Cap

Dichotomous indicator total rehab charges
over the cap, 1=yes, O=no

135

VariabJe List

# VariabJe

Label

109 Total_Payments
Total payments over study time period
153 Total_Payments_1 Total payments over study time period
997
149 Total - Rehab- Carri Total payments carrier files
er_pmt

147 Total_Rehab_pmt Total payments rehab
3 age_group
Categorized Age Group
4 ageaprox
Continuous Age Approximation (set as central
point of age group)

8
113
11
9
135
1
18
6
44
59
62
95
80
77
137
136
43
58
61
94

black

Indicator of black race

carner zero

Indicator of Carrier (Part B) payment of zero

dd

Categorized discharge disposition

deathind

Died during study, 1=yes, O=no

expi red _i nhosp

Dichotomous indicator expired in hospital,
1=yes,O=no

id

Study su bject identifier code

los

Hospital Length of Stay

male

Indicator of male gender, 1=yes, O=no

num- CA- bills

Number of bills, Carrier
Number of bills, DME

num- DME- bills
num- HH- bills

,

Number of bills, Home Health
~

num- NH- bills
num- OP- bills

Number of bills, Nursing Home

num_hosp_bills

Number of bills, hospital

Number of bills, Outpatient

num- rehab- CAbill Number of rehab bills, Carrier
s
num- rehab- bills
pmt_amt_CA

Number of rehab bills
Payment amount, Carrier

pmt_amt_DME

Payment amount, DME

pmt_amt_HH

Payment amount, HH

pmt_amt_NH

Payment amount, NH
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Variable List

# Variable

Label

79 pmt_amt_OP

Payment amount, OP

76 pmt_amt_hosp

Payment amount, Hospital

41 prior_hasp

Indicator of prior hospitalization , 1= yes O=no

40 prior_stroke

Indicator of prior stroke, 1= yes O=no

7 race
138 rehab

RACE
Indicator of any rehab, 1= yes O=no

68 rehab- num ICD57 Number of rehab bills stemming from code
1ptHH_bilis
571, for PT HH
101 rehab- num- ICD57 Number of rehab bills stemming from code
571, for PT NH
1ptNH_bilis
86 rehab- num- ICD57 Number of rehab bills stemming from code
1ptOP_bills
571, for PT OP
71 rehab- num- ICD57 Number of rehab bills stemming from code
571, for OT HH
20tHH bills
104 rehab- num- ICD57 Number of rehab bills stemming from code
20tNH bills
571, for OT NH
89 rehab- num- ICD57 Number of rehab bills stemming from code
571 , for OT ,..,OP
2otOP bills
74 rehab- num- ICD57 Number of reh'ab bills stemming from code
3slpHH_bilis
571, for SLP HH
107 rehab- num- ICD57 Number of rehab bills stemming from code
3slpNH_bilis
571 , for SLP NH
...

92 rehab- num- ICD57 Number of rehab bills stemming from code
571, for SLP OP
3slpOP_bills
65 rehab- num- ICD57 Number of rehab bills stemming from code
genHH_bilis
571, for GEN HH
98 rehab- num- ICD57 Number of rehab bills stemming from code
genNH_bilis
571, for GEN NH
83 rehab- num- ICD57 Number of rehab bills stemming from code
571, for GEN OP
genOP_bills
47 rehab_num_genC
A bills

Number of rehab Carrier bills, General

53 rehab- num- otCA- Number of rehab Carrier bills, OT
bills
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50 rehab_num_ptCA_ Number of rehab Carrier bills, PT
bills
.

56 rehab_num_slpCA Number of rehab Carrier bills, SlP

'"

-

bills

67 rehab_pmt_amt_1
f.

.

CD571 ptHH

100 rehab_pmt_amt_1
:~

".

,

CD571ptNH

.$

85 rehab_pmt_amt_1
CD571ptOP

, 70 rehab_pmt_amt_1
CD5720tHH

iJ>

ClM- PMT AMT
ClM- PMT- AMT
ClM- PMT AMT
ClM- PMT- AMT

t'

,

,N

1031 rehab_pmt_amt_1
CD5720tNH

ClM- PMT AMT

88 rehab_pmt_amt_1

ClM- PMT- AMT

~

CD572otOP

'"

73 rehab_pmt_amt_1
CD573slpHH

ClM- PMT AMT

106 rehab_pmt_amt_1

ClM PMT ,AMT

CD573slpNH

~

91 rehab_pmt_amt_1
CD573slpOP

ii,

~

64 rehab_pmt_amt_1
CD57genHH
91'~

-

-

ClM- ' PMT- AMT
ClM- PMT- AMT
.,

rehab_pmt_amt_1
CD57genNH

ClM- PMT- AMT

82 rehab_pmt_amt_1
CD57genOP

ClM- PMT AMT

t' ".
#

"

46 rehab_pmt_amt_g ClM - PMT AMT
enCA

521 rehab_pmt_amt_ot ClM- PMT- AMT
i!J

CA

©

49 rehab_pmt_amt_pt ClM- PMT- AMT
CA

.5
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Variable list

# Variable

label

55 rehab_pmt_amt_sl ClM- PMT- AMT
pCA
66 rehab_totchg_ICD ClM- TOT- CHRG- AMT
571 ptHH
,,;

99 rehab_totchg_ICD ClM- TOT- CHRG- AMT
571 ptNH
84 rehab_totchg_ICD ClM- TOT- CHRG- AMT
571ptOP
69 rehab_totchg_ICD ClM- TOT- CHRG- AMT
5720tHH
102 rehab_totchg_ICD ClM- TOT- CHRG- AMT
5720tNH
87 rehab_totchg_ICD ClM- TOT- CHRG- AMT
572otOP
:) .

..?i;

72 rehab_totchg_ICD ClM- TOT- CHRG- AMT
573slpHH
105 rehab_totchg_ICD ClM- TOT- CHRG- AMT
573slpNH
/

90 rehab_totchg_ICD ClM - TOT573slpOP

~HRG

-

AMT

63 rehab_totchg_ICD ClM- TOT- CHRG- AMT
57genHH

'i'

,..

96 rehab_totchg_ICD ClM- TOT- CHRG- AMT
~

57genNH

81 rehab_totchg_ICD ClM - TOT- CHRG- AMT
57genOP
45 rehab_totchg_gen
CA

Total charges amount Carrier, General

51 rehab_totchg_otC
A

Total charges amount Carrier, aT

48 rehab_ totchg_ptC
A

Total charges amount Carrier, PT

~

54 rehab_totchg_slpC Total charges amount Carrier, SlP
A
,

5 sex

Gender
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Variable List

# Variable

Label

14 stroke date

Date of Stroke or index date (for control
subjects)

10 stroke date04

Date of Stroke in 2004 (if any)

123 stroke date97

Date of Stroke in 1997 (if any)

19 stus cd

PTNT- DSCHRGSTUS
-CD

42 totch9_CA

Total charges for carrier files

57 totch9_DME

totch9_DME

60 totch9_HH

ClM- TOT- CHRG- AMT

93 totch9_NH
78 totch9_0P

ClM- TOT- CHRG- AMT
ClM- TOT- CHRG- AMT

75 totch9_hosp

ClM- TOT- CHRG- AMT
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Appendix B. -Billing C ,o des used to Identify Rehabilitation Services
1997 HCPCS/CPT Rehabilitation Codes

95831

Massage

95851

Manual Therapy

97010

Supervised application of hot or cold packs

97012

Supervised application of traction

97014

Supervised application of electrical stimulation

97016

Supervised

97018

Supervised application of paraffin bath

97020

Supervised application of microwave

97022

Supervised application of whirlpool

97024

Supervised application of diathermy

97026

Supervised application of infrared

97028

Supervised application of ultraviolet

97032

Application of electrical stimulation

97033

Application of iontophoresis

97034

Application of contrast baths

97035

Application "'o f ultrasound

97036

Application of hubbard tank

97039

Application of unlisted modality

97110

Therapeutic procedure 15 mins)

97112

Neuromuscular reeducation

97113

Aquatic therapy

97116

Gait Training

97122

Traction

97124

Massage

97139

Unlisted therapeutic procedure

97150

Therapeutic Procedure (group)

~pplication

of vasopneumatic devices

141

97250

Myofascial release/soft tissue mobilization

97260

Manipulation

97261

Manipulation each additional area

97265

Joint mobilization

97504

Orthotics fitting and training

97520

Prosthetic training

97530

Therapeutic activities, direct

97535 (OT)

Self carel home management training

97537 (OT)

Community/work re-intergration

97542

Wheelchair management

97545

Work hardening/conditioning (initial 2 hrs)

97546

Work hardening/conditioning (additional 1 hr)

97703

Checkout for orthotic/prosthetic use

97750

Physical performance test or measurement

97770

Development of cognitive skills

97799

Unlisted physical
medicine/rehabilitation service
,
,.

'i
I

SLP Codes

HeReS/CPT . Description ,
92506
92507
92508
92525
92526

~

t\

M

Evaluation or speech, language, voice,
communication, etc.
Treatment of speech, language, voice,
communication, etc.
Treatment of speech, language, voice,
communication, etc. (group)
Evaluation of swallowing and oral function for
feeding
Treatment of swallowing dysfunction and/or
oral function for feeding

142

1997 and 2004 ICD-9-CM Thera

V57.0x
V57.4
V57.8x
V57.9

143

2004 Outpatient Provider HCPCS Codes with PT modifier
:@

%

HCPCS

ICPT

Ii!

Frequency Descrjption

95831

1

Muscle Testing

95851

5

Range of Motion Measure

97001

75

PT Evaluation

97002

19

PT Re-evaluation

97003

4

OT Evaluation

97010

6

HotlCold Packs

97012

63

Traction

97022

3

Whirlpool

97024

1

Diathermy

97032

155

Electrical Stimulation

97033

11

Iontophoresis

97035

124

Ultrasound

97036

1

97110

1163

Therapy Procedure

97112

217

Neuromuscular Re-education

Hubbard Tank

,

97116

82

Gait Tralnir)g

97124

30

Massage

97140

102

Manual Therapy

97150

45

Therapy Procedure (Group)

97530

206

Therapy Activities

97535

36

Activity of Daily Living Training

97542

2

Wheelchair Management

97750

9

Physical Performance Test

G0283

10

Electrical Stimulation

Total

2370

;:"{

144

2004 Coded as PT without Modifier Code
97001

PT Evaluation

97002

PT Re-Evaluation

97110

Therapy Procedure

97 112

Neuromuscular Re-education

97116

Gait Training

2004 Outpatient HCPCS Codes with OT Modifier Code

97003

17

OT Evaluation

97004

3

OTRe-Evaluation

97010

3

HoUCoid Packs

97032

4

Electrical Stimulation

97033

14

Iontophoresis

97035

7

Ultrasound

971 10

114

Therapy Procedure

971 12

47

Neuromuscular Re-education

97140

11

Manual Therapy

97150

1

Therapy Procedure (Group)

97530

33

Therapy Activities

97533

3

Sensory Integrative Techniques

97535

19

Activities of Daily Living Tra.ining

A4556

1

Electrodes

G0283

25

Electrical Stimulation

Total

302
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2004 Coded as OT without Modifier Code
97003

OT Evaluation

97004

OT Re-Evaluation
Occu ational thera services er da
Services of an OT in home health or
hos ice 15 mins
Services of an OT in home health or
hos ice 15 mins
Services performed by an OT in
maintenance
15 mins
OT, in the home, er diem

G0129
G0152
G0158
G0160
S9129

2004 Coded as PT or OT without Modifier Code
97124

Massage

97140

Manual Therapy

97150

Therapy Procedure (Group)

97530

Therapy Activities

97532

Cognitive skills development

97533

Sensory Integrative Techniques
".

97535

Activities of Daily Living Training

97537
97542
97545

Work Reinte ration Trainin
Wheelchair Mana ement
Work conditioning or hardening (initial 2
hrs
Work conditioning or hardening
additional 1 hr

97546
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2004 Out atient HCPCS Codes with SLP Modifier Code

1

Evaluation Swallowing

1

Flex Scope Swallowing

8

Neurobehavioral Status Exam

11
2004 Coded as SLP without Modifier Code
92506

Evaluation SLP

92507

Treatment of speech, lang., voice,
comm., or aud. disorder

92508

Treatment of speech, lang., voice,
comm., or aud. Disorder (group)

92526

Treatment of swallowing dysfunction

92610

Evaluation Swallowing

92612

Flex Scope Swallowing
,

92626

Evaluation of .auditory
status (1 hr)

92627

Evaluation of auditory rehabilitation
status (15 mins)

rehabilitation

